Project
Illumina Body Map 2 (GSE30611)
Navigation
Downloads
Results for ELF2_GABPA_ELF5
Z-value: 3.63
Motif logo
Transcription factors associated with ELF2_GABPA_ELF5
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
ELF2
|
ENSG00000109381.20 | E74 like ETS transcription factor 2 |
|
GABPA
|
ENSG00000154727.11 | GA binding protein transcription factor subunit alpha |
|
ELF5
|
ENSG00000135374.11 | E74 like ETS transcription factor 5 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| GABPA | hg38_v1_chr21_+_25734948_25734988 | 0.65 | 6.7e-05 | Click! |
| ELF2 | hg38_v1_chr4_-_139084289_139084496 | 0.45 | 9.4e-03 | Click! |
| ELF5 | hg38_v1_chr11_-_34513750_34513771 | -0.11 | 5.4e-01 | Click! |
Activity profile of ELF2_GABPA_ELF5 motif
Sorted Z-values of ELF2_GABPA_ELF5 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of ELF2_GABPA_ELF5
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.3 | 37.3 | GO:0098758 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 5.1 | 15.3 | GO:1902567 | negative regulation of eosinophil activation(GO:1902567) |
| 4.6 | 13.7 | GO:0001808 | negative regulation of type IV hypersensitivity(GO:0001808) |
| 4.4 | 13.1 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
| 4.3 | 21.4 | GO:0002357 | defense response to tumor cell(GO:0002357) |
| 4.3 | 17.1 | GO:2000471 | regulation of hematopoietic stem cell migration(GO:2000471) positive regulation of hematopoietic stem cell migration(GO:2000473) |
| 4.2 | 21.1 | GO:0052056 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
| 3.9 | 11.7 | GO:0019085 | early viral transcription(GO:0019085) |
| 3.8 | 3.8 | GO:0071226 | response to molecule of fungal origin(GO:0002238) cellular response to molecule of fungal origin(GO:0071226) |
| 3.7 | 3.7 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 3.5 | 14.1 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 3.4 | 17.1 | GO:0032765 | positive regulation of mast cell cytokine production(GO:0032765) |
| 3.4 | 20.2 | GO:0006050 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 3.3 | 13.3 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 3.3 | 3.3 | GO:0071650 | negative regulation of chemokine (C-C motif) ligand 5 production(GO:0071650) |
| 3.2 | 22.7 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 3.2 | 25.3 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
| 3.1 | 12.5 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 3.1 | 12.3 | GO:0016333 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 3.0 | 17.9 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 2.9 | 26.3 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 2.9 | 8.8 | GO:0061485 | memory T cell proliferation(GO:0061485) |
| 2.9 | 17.3 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 2.8 | 16.9 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 2.8 | 2.8 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
| 2.8 | 5.5 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
| 2.7 | 10.9 | GO:0051413 | response to cortisone(GO:0051413) |
| 2.7 | 8.2 | GO:0042946 | glucoside transport(GO:0042946) |
| 2.7 | 8.1 | GO:1902905 | positive regulation of fibril organization(GO:1902905) |
| 2.7 | 16.0 | GO:0043366 | beta selection(GO:0043366) |
| 2.7 | 10.7 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
| 2.6 | 7.9 | GO:0036451 | cap mRNA methylation(GO:0036451) |
| 2.6 | 10.6 | GO:0052255 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 2.6 | 5.3 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
| 2.6 | 7.8 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 2.5 | 7.6 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
| 2.5 | 7.5 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 2.5 | 7.5 | GO:0034769 | basement membrane disassembly(GO:0034769) |
| 2.5 | 12.3 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 2.4 | 4.9 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
| 2.4 | 12.1 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 2.4 | 23.5 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 2.3 | 2.3 | GO:0034125 | negative regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034125) |
| 2.3 | 6.9 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
| 2.3 | 16.0 | GO:2000782 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
| 2.3 | 6.9 | GO:0071613 | granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
| 2.3 | 13.7 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
| 2.3 | 6.8 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 2.3 | 22.7 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 2.3 | 6.8 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 2.3 | 6.8 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
| 2.3 | 6.8 | GO:0010931 | macrophage tolerance induction(GO:0010931) regulation of macrophage tolerance induction(GO:0010932) positive regulation of macrophage tolerance induction(GO:0010933) |
| 2.2 | 8.9 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
| 2.1 | 6.4 | GO:0030451 | regulation of complement activation, alternative pathway(GO:0030451) negative regulation of complement activation, alternative pathway(GO:0045957) |
| 2.1 | 6.4 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 2.1 | 2.1 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 2.1 | 8.3 | GO:0071335 | submandibular salivary gland formation(GO:0060661) hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
| 2.1 | 2.1 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
| 2.0 | 16.4 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 2.0 | 8.1 | GO:2000753 | regulation of phospholipid scramblase activity(GO:1900161) positive regulation of phospholipid scramblase activity(GO:1900163) regulation of glucosylceramide catabolic process(GO:2000752) positive regulation of glucosylceramide catabolic process(GO:2000753) regulation of sphingomyelin catabolic process(GO:2000754) positive regulation of sphingomyelin catabolic process(GO:2000755) |
| 2.0 | 18.2 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 2.0 | 22.2 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 2.0 | 10.0 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
| 1.9 | 5.8 | GO:1901895 | negative regulation of calcium-transporting ATPase activity(GO:1901895) |
| 1.9 | 13.4 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 1.9 | 5.7 | GO:0019417 | sulfur oxidation(GO:0019417) |
| 1.9 | 1.9 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
| 1.8 | 9.2 | GO:1904882 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 1.8 | 7.4 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
| 1.8 | 5.5 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
| 1.8 | 3.7 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 1.8 | 7.3 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
| 1.8 | 10.8 | GO:2001107 | negative regulation of establishment of T cell polarity(GO:1903904) negative regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001107) |
| 1.8 | 7.2 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 1.8 | 5.4 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 1.8 | 7.2 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
| 1.8 | 3.6 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 1.8 | 7.1 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 1.8 | 1.8 | GO:0002304 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
| 1.8 | 5.3 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
| 1.8 | 5.3 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
| 1.8 | 8.8 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 1.7 | 8.7 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 1.7 | 3.4 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
| 1.7 | 6.9 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
| 1.7 | 5.1 | GO:2000706 | amniotic stem cell differentiation(GO:0097086) negative regulation of dense core granule biogenesis(GO:2000706) negative regulation of mesenchymal stem cell differentiation(GO:2000740) regulation of amniotic stem cell differentiation(GO:2000797) negative regulation of amniotic stem cell differentiation(GO:2000798) |
| 1.7 | 13.6 | GO:0038123 | toll-like receptor TLR1:TLR2 signaling pathway(GO:0038123) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
| 1.7 | 6.8 | GO:1904761 | negative regulation of myofibroblast differentiation(GO:1904761) |
| 1.7 | 6.8 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
| 1.7 | 5.1 | GO:0035048 | splicing factor protein import into nucleus(GO:0035048) |
| 1.7 | 8.4 | GO:2000538 | regulation of cGMP-mediated signaling(GO:0010752) regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
| 1.7 | 5.0 | GO:1903004 | regulation of protein K63-linked deubiquitination(GO:1903004) positive regulation of protein K63-linked deubiquitination(GO:1903006) |
| 1.7 | 5.0 | GO:0002432 | granuloma formation(GO:0002432) |
| 1.7 | 1.7 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
| 1.7 | 5.0 | GO:1904844 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 1.7 | 41.3 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 1.6 | 8.2 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
| 1.6 | 4.8 | GO:0000393 | generation of catalytic spliceosome for second transesterification step(GO:0000350) spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 1.6 | 12.8 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
| 1.6 | 4.8 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 1.6 | 6.3 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 1.6 | 4.7 | GO:0002380 | immunoglobulin secretion involved in immune response(GO:0002380) |
| 1.6 | 10.9 | GO:0006154 | adenosine catabolic process(GO:0006154) inosine biosynthetic process(GO:0046103) |
| 1.6 | 4.7 | GO:0035698 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) regulation of T cell extravasation(GO:2000407) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
| 1.5 | 10.8 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 1.5 | 1.5 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
| 1.5 | 6.2 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
| 1.5 | 9.2 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 1.5 | 6.1 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
| 1.5 | 9.1 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 1.5 | 6.1 | GO:2000607 | regulation of cell proliferation involved in mesonephros development(GO:2000606) negative regulation of cell proliferation involved in mesonephros development(GO:2000607) fibroblast growth factor receptor signaling pathway involved in ureteric bud formation(GO:2000699) glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation(GO:2000701) regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation(GO:2000702) negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation(GO:2000703) regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation(GO:2000733) negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation(GO:2000734) |
| 1.5 | 4.5 | GO:0046041 | ITP metabolic process(GO:0046041) |
| 1.5 | 25.7 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
| 1.5 | 6.0 | GO:0043335 | protein unfolding(GO:0043335) |
| 1.5 | 1.5 | GO:0006829 | zinc II ion transport(GO:0006829) |
| 1.5 | 218.3 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 1.5 | 4.4 | GO:0043485 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 1.4 | 1.4 | GO:1904875 | regulation of DNA ligase activity(GO:1904875) |
| 1.4 | 11.6 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
| 1.4 | 10.1 | GO:0022614 | membrane to membrane docking(GO:0022614) |
| 1.4 | 4.3 | GO:0009826 | unidimensional cell growth(GO:0009826) |
| 1.4 | 8.6 | GO:1903232 | melanosome assembly(GO:1903232) |
| 1.4 | 2.9 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
| 1.4 | 1.4 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 1.4 | 28.3 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 1.4 | 5.6 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 1.4 | 5.6 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
| 1.4 | 2.8 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 1.4 | 8.2 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
| 1.4 | 5.5 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
| 1.4 | 13.7 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
| 1.4 | 6.8 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 1.3 | 4.0 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
| 1.3 | 8.0 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 1.3 | 9.4 | GO:0032494 | response to peptidoglycan(GO:0032494) |
| 1.3 | 4.0 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
| 1.3 | 9.3 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 1.3 | 4.0 | GO:0051714 | negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) positive regulation of cytolysis in other organism(GO:0051714) |
| 1.3 | 6.6 | GO:0007172 | signal complex assembly(GO:0007172) |
| 1.3 | 17.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 1.3 | 11.8 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
| 1.3 | 3.9 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
| 1.3 | 2.6 | GO:1902623 | negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
| 1.3 | 2.6 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
| 1.3 | 1.3 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
| 1.3 | 7.7 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
| 1.3 | 11.6 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 1.3 | 3.8 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
| 1.3 | 5.1 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
| 1.3 | 5.1 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 1.3 | 6.3 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 1.3 | 2.5 | GO:0033023 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
| 1.3 | 5.0 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
| 1.3 | 5.0 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
| 1.3 | 7.5 | GO:0060369 | positive regulation of natural killer cell cytokine production(GO:0002729) positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
| 1.2 | 5.0 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 1.2 | 2.5 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
| 1.2 | 6.2 | GO:1902568 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 1.2 | 23.4 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
| 1.2 | 3.7 | GO:0044725 | chromatin reprogramming in the zygote(GO:0044725) |
| 1.2 | 4.9 | GO:0002384 | hepatic immune response(GO:0002384) |
| 1.2 | 3.6 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
| 1.2 | 8.4 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 1.2 | 32.0 | GO:0045730 | respiratory burst(GO:0045730) |
| 1.2 | 3.5 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
| 1.2 | 5.9 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 1.2 | 3.5 | GO:0035508 | positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
| 1.2 | 7.0 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
| 1.2 | 1.2 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
| 1.2 | 7.0 | GO:0034227 | tRNA thio-modification(GO:0034227) |
| 1.2 | 7.0 | GO:0050904 | diapedesis(GO:0050904) |
| 1.2 | 1.2 | GO:0002442 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
| 1.2 | 6.9 | GO:0002084 | protein depalmitoylation(GO:0002084) |
| 1.1 | 6.9 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 1.1 | 2.3 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
| 1.1 | 5.7 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 1.1 | 11.4 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
| 1.1 | 4.6 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 1.1 | 3.4 | GO:0015734 | taurine transport(GO:0015734) |
| 1.1 | 4.5 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 1.1 | 10.0 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 1.1 | 10.0 | GO:0033183 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
| 1.1 | 4.5 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 1.1 | 6.6 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
| 1.1 | 2.2 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
| 1.1 | 15.4 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 1.1 | 3.3 | GO:0036245 | cellular response to menadione(GO:0036245) |
| 1.1 | 2.2 | GO:0032258 | CVT pathway(GO:0032258) |
| 1.1 | 1.1 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
| 1.1 | 6.6 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
| 1.1 | 8.8 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 1.1 | 3.3 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 1.1 | 3.3 | GO:0071529 | cementum mineralization(GO:0071529) |
| 1.1 | 1.1 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
| 1.1 | 6.5 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 1.1 | 4.3 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
| 1.1 | 3.2 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
| 1.1 | 5.4 | GO:0042779 | tRNA 3'-trailer cleavage, endonucleolytic(GO:0034414) tRNA 3'-trailer cleavage(GO:0042779) |
| 1.1 | 3.2 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 1.1 | 8.6 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 1.1 | 17.1 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 1.1 | 4.3 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 1.1 | 3.2 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
| 1.1 | 3.2 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 1.0 | 5.2 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
| 1.0 | 1.0 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
| 1.0 | 4.1 | GO:1904806 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 1.0 | 1.0 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 1.0 | 3.1 | GO:0090340 | positive regulation of high-density lipoprotein particle assembly(GO:0090108) positive regulation of secretion of lysosomal enzymes(GO:0090340) |
| 1.0 | 4.1 | GO:1902524 | positive regulation of protein K48-linked ubiquitination(GO:1902524) |
| 1.0 | 7.2 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 1.0 | 1.0 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
| 1.0 | 4.1 | GO:0033037 | polysaccharide localization(GO:0033037) |
| 1.0 | 1.0 | GO:0072387 | flavin adenine dinucleotide metabolic process(GO:0072387) |
| 1.0 | 4.0 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) |
| 1.0 | 19.2 | GO:0075713 | establishment of integrated proviral latency(GO:0075713) |
| 1.0 | 3.0 | GO:2000320 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
| 1.0 | 5.0 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 1.0 | 9.0 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 1.0 | 3.0 | GO:0046108 | uridine metabolic process(GO:0046108) |
| 1.0 | 12.0 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
| 1.0 | 7.0 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 1.0 | 8.0 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
| 1.0 | 5.0 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 1.0 | 9.9 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 1.0 | 19.9 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
| 1.0 | 6.0 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 1.0 | 13.8 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 1.0 | 5.9 | GO:0019348 | dolichol metabolic process(GO:0019348) |
| 1.0 | 2.9 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
| 1.0 | 2.9 | GO:0002399 | MHC class II protein complex assembly(GO:0002399) |
| 1.0 | 4.9 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
| 1.0 | 1.0 | GO:1901741 | regulation of myoblast fusion(GO:1901739) positive regulation of myoblast fusion(GO:1901741) |
| 1.0 | 4.9 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 1.0 | 23.2 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
| 1.0 | 5.8 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 1.0 | 1.9 | GO:1900368 | regulation of RNA interference(GO:1900368) |
| 1.0 | 7.7 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 1.0 | 5.8 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 1.0 | 1.9 | GO:0019521 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 1.0 | 3.8 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 1.0 | 2.9 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) axial mesoderm formation(GO:0048320) |
| 0.9 | 19.9 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.9 | 5.7 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
| 0.9 | 1.9 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.9 | 6.6 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 0.9 | 0.9 | GO:0016078 | tRNA catabolic process(GO:0016078) |
| 0.9 | 83.0 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.9 | 6.6 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.9 | 5.6 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 0.9 | 8.4 | GO:0002353 | kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
| 0.9 | 4.6 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.9 | 8.3 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.9 | 13.8 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.9 | 3.7 | GO:0036229 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.9 | 2.8 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 0.9 | 0.9 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
| 0.9 | 8.2 | GO:0051873 | killing by host of symbiont cells(GO:0051873) |
| 0.9 | 1.8 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
| 0.9 | 23.5 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
| 0.9 | 8.1 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
| 0.9 | 7.2 | GO:0000023 | maltose metabolic process(GO:0000023) |
| 0.9 | 6.3 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 0.9 | 2.7 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 0.9 | 2.7 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.9 | 2.7 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.9 | 5.3 | GO:2001153 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 0.9 | 32.0 | GO:0035455 | response to interferon-alpha(GO:0035455) |
| 0.9 | 2.7 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.9 | 8.0 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.9 | 3.5 | GO:0000451 | rRNA 2'-O-methylation(GO:0000451) |
| 0.9 | 3.5 | GO:1902229 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) |
| 0.9 | 0.9 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
| 0.9 | 4.4 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.9 | 2.6 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
| 0.9 | 5.3 | GO:0035696 | monocyte extravasation(GO:0035696) |
| 0.9 | 4.4 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
| 0.9 | 1.7 | GO:0046832 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.9 | 18.0 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.9 | 1.7 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
| 0.9 | 6.0 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.9 | 3.4 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
| 0.9 | 9.4 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
| 0.9 | 14.5 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 0.8 | 5.1 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 0.8 | 11.9 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.8 | 0.8 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
| 0.8 | 11.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
| 0.8 | 1.7 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
| 0.8 | 3.4 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
| 0.8 | 2.5 | GO:1903123 | regulation of thioredoxin peroxidase activity(GO:1903123) negative regulation of thioredoxin peroxidase activity(GO:1903124) negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation(GO:1903125) Wnt signalosome assembly(GO:1904887) negative regulation of peroxidase activity(GO:2000469) |
| 0.8 | 5.0 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.8 | 0.8 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
| 0.8 | 4.2 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
| 0.8 | 6.7 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
| 0.8 | 17.6 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
| 0.8 | 0.8 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.8 | 0.8 | GO:2000563 | CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 0.8 | 5.0 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.8 | 0.8 | GO:0071492 | cellular response to UV-A(GO:0071492) |
| 0.8 | 0.8 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
| 0.8 | 9.1 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.8 | 1.6 | GO:1990180 | mitochondrial tRNA 3'-end processing(GO:1990180) |
| 0.8 | 3.3 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.8 | 2.4 | GO:0045554 | TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
| 0.8 | 3.3 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.8 | 3.3 | GO:0035261 | external genitalia morphogenesis(GO:0035261) |
| 0.8 | 6.5 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
| 0.8 | 32.3 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.8 | 2.4 | GO:0042144 | vacuole fusion, non-autophagic(GO:0042144) |
| 0.8 | 3.2 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
| 0.8 | 7.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.8 | 5.6 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.8 | 7.9 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
| 0.8 | 1.6 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
| 0.8 | 5.5 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.8 | 5.5 | GO:0046061 | dATP catabolic process(GO:0046061) |
| 0.8 | 15.8 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.8 | 3.9 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.8 | 9.4 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.8 | 2.4 | GO:0045357 | interferon-beta biosynthetic process(GO:0045350) regulation of interferon-beta biosynthetic process(GO:0045357) positive regulation of interferon-beta biosynthetic process(GO:0045359) |
| 0.8 | 6.3 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.8 | 2.3 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
| 0.8 | 53.1 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
| 0.8 | 0.8 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.8 | 3.9 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.8 | 7.0 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
| 0.8 | 10.0 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.8 | 4.6 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 0.8 | 6.9 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) |
| 0.8 | 2.3 | GO:0055094 | response to lipoprotein particle(GO:0055094) |
| 0.8 | 13.0 | GO:0019081 | viral translation(GO:0019081) |
| 0.8 | 3.8 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
| 0.8 | 3.8 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.8 | 2.3 | GO:1990619 | histone H3-K9 deacetylation(GO:1990619) |
| 0.8 | 3.8 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) interleukin-3-mediated signaling pathway(GO:0038156) |
| 0.8 | 2.3 | GO:0097032 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.8 | 2.3 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.8 | 2.3 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
| 0.8 | 10.5 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.7 | 3.7 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
| 0.7 | 5.2 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.7 | 6.6 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 0.7 | 0.7 | GO:2001187 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
| 0.7 | 13.2 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.7 | 14.5 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.7 | 2.9 | GO:1903936 | cellular response to sodium arsenite(GO:1903936) |
| 0.7 | 5.8 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.7 | 2.2 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 0.7 | 14.4 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.7 | 0.7 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
| 0.7 | 1.4 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
| 0.7 | 11.3 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.7 | 2.8 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
| 0.7 | 4.2 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
| 0.7 | 4.2 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.7 | 7.0 | GO:0016139 | glycoside catabolic process(GO:0016139) |
| 0.7 | 4.2 | GO:1904383 | response to sodium phosphate(GO:1904383) |
| 0.7 | 0.7 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.7 | 15.3 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 0.7 | 2.8 | GO:0060922 | cardiac septum cell differentiation(GO:0003292) atrioventricular node cell differentiation(GO:0060922) atrioventricular node cell development(GO:0060928) |
| 0.7 | 2.1 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.7 | 1.4 | GO:2001301 | lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
| 0.7 | 4.1 | GO:0010957 | negative regulation of vitamin D biosynthetic process(GO:0010957) |
| 0.7 | 2.7 | GO:0035936 | testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 0.7 | 4.8 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 0.7 | 2.0 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.7 | 2.7 | GO:0035977 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
| 0.7 | 13.5 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.7 | 14.0 | GO:1990776 | response to angiotensin(GO:1990776) |
| 0.7 | 3.3 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.7 | 4.0 | GO:0034670 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
| 0.7 | 2.0 | GO:1903259 | exon-exon junction complex disassembly(GO:1903259) |
| 0.7 | 6.0 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
| 0.7 | 1.3 | GO:0019042 | viral latency(GO:0019042) |
| 0.7 | 8.6 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.7 | 4.6 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.7 | 6.6 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.7 | 1.3 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
| 0.7 | 3.3 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 0.7 | 3.3 | GO:0046016 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) carbon catabolite activation of transcription(GO:0045991) positive regulation of transcription by glucose(GO:0046016) |
| 0.7 | 3.3 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.7 | 2.0 | GO:1903450 | regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
| 0.6 | 1.9 | GO:0039519 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) modulation by virus of host autophagy(GO:0039519) suppression by virus of host autophagy(GO:0039521) |
| 0.6 | 2.6 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.6 | 1.3 | GO:0010273 | detoxification of copper ion(GO:0010273) regulation of iron ion transport(GO:0034756) regulation of iron ion transmembrane transport(GO:0034759) stress response to copper ion(GO:1990169) |
| 0.6 | 5.2 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) |
| 0.6 | 6.4 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.6 | 1.9 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
| 0.6 | 12.2 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.6 | 1.9 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
| 0.6 | 2.5 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.6 | 6.4 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.6 | 5.7 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.6 | 1.3 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.6 | 1.9 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.6 | 3.8 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
| 0.6 | 1.9 | GO:0045175 | basal protein localization(GO:0045175) |
| 0.6 | 11.9 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.6 | 8.1 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 0.6 | 15.0 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
| 0.6 | 6.9 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.6 | 5.6 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.6 | 1.8 | GO:0031497 | chromatin assembly(GO:0031497) |
| 0.6 | 1.8 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
| 0.6 | 4.9 | GO:0032218 | riboflavin transport(GO:0032218) |
| 0.6 | 7.4 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.6 | 1.2 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.6 | 15.3 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.6 | 2.4 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
| 0.6 | 6.7 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.6 | 3.0 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.6 | 2.4 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 0.6 | 2.4 | GO:0021569 | rhombomere 3 development(GO:0021569) |
| 0.6 | 7.9 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.6 | 13.3 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.6 | 7.9 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.6 | 0.6 | GO:0003264 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) regulation of secondary heart field cardioblast proliferation(GO:0003266) positive regulation of secondary heart field cardioblast proliferation(GO:0072513) regulation of cell proliferation involved in heart morphogenesis(GO:2000136) |
| 0.6 | 1.2 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
| 0.6 | 3.6 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.6 | 4.8 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.6 | 3.0 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.6 | 3.6 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.6 | 1.8 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
| 0.6 | 0.6 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
| 0.6 | 5.3 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
| 0.6 | 11.3 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
| 0.6 | 1.8 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
| 0.6 | 11.2 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
| 0.6 | 2.4 | GO:0080009 | mRNA methylation(GO:0080009) |
| 0.6 | 3.5 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
| 0.6 | 1.8 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.6 | 7.0 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.6 | 1.7 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
| 0.6 | 2.9 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
| 0.6 | 1.7 | GO:0032917 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.6 | 8.1 | GO:0043368 | positive T cell selection(GO:0043368) |
| 0.6 | 9.8 | GO:0006293 | nucleotide-excision repair, preincision complex stabilization(GO:0006293) |
| 0.6 | 3.4 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
| 0.6 | 2.3 | GO:0061386 | closure of optic fissure(GO:0061386) |
| 0.6 | 9.7 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.6 | 10.3 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
| 0.6 | 1.1 | GO:0032310 | prostaglandin secretion(GO:0032310) |
| 0.6 | 2.8 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
| 0.6 | 5.1 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.6 | 7.9 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.6 | 1.7 | GO:0033082 | natural killer cell differentiation involved in immune response(GO:0002325) regulation of natural killer cell differentiation involved in immune response(GO:0032826) regulation of extrathymic T cell differentiation(GO:0033082) |
| 0.6 | 7.9 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
| 0.6 | 9.0 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) |
| 0.6 | 3.4 | GO:0032743 | positive regulation of interleukin-2 production(GO:0032743) |
| 0.6 | 18.5 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
| 0.6 | 0.6 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 0.6 | 3.9 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.6 | 0.6 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.6 | 3.9 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 0.6 | 8.3 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.6 | 2.8 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.6 | 1.7 | GO:0060309 | elastin catabolic process(GO:0060309) |
| 0.6 | 1.1 | GO:2000681 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.6 | 1.1 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
| 0.6 | 2.8 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
| 0.5 | 7.1 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
| 0.5 | 2.7 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
| 0.5 | 18.6 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 0.5 | 1.6 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
| 0.5 | 1.1 | GO:1903438 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.5 | 1.6 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.5 | 1.6 | GO:0070902 | mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 0.5 | 3.8 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.5 | 2.7 | GO:0032796 | uropod organization(GO:0032796) |
| 0.5 | 10.3 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.5 | 1.6 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
| 0.5 | 9.2 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.5 | 11.3 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.5 | 7.5 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.5 | 1.6 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 0.5 | 2.1 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
| 0.5 | 4.3 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.5 | 5.9 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.5 | 6.4 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.5 | 8.0 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
| 0.5 | 21.2 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
| 0.5 | 3.7 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
| 0.5 | 1.6 | GO:0048162 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
| 0.5 | 4.2 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
| 0.5 | 1.6 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.5 | 4.7 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.5 | 4.7 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
| 0.5 | 3.7 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.5 | 2.1 | GO:0042256 | mature ribosome assembly(GO:0042256) |
| 0.5 | 2.6 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
| 0.5 | 4.2 | GO:1901563 | cellular response to camptothecin(GO:0072757) response to camptothecin(GO:1901563) |
| 0.5 | 2.1 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 0.5 | 1.0 | GO:0071863 | regulation of cell proliferation in bone marrow(GO:0071863) positive regulation of cell proliferation in bone marrow(GO:0071864) |
| 0.5 | 372.0 | GO:0042119 | neutrophil activation(GO:0042119) |
| 0.5 | 2.1 | GO:0006517 | protein deglycosylation(GO:0006517) |
| 0.5 | 6.7 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
| 0.5 | 1.5 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
| 0.5 | 2.0 | GO:0033320 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
| 0.5 | 1.5 | GO:0021503 | neural fold bending(GO:0021503) |
| 0.5 | 1.5 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.5 | 5.6 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
| 0.5 | 5.1 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.5 | 2.0 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
| 0.5 | 2.5 | GO:0001945 | lymph vessel development(GO:0001945) |
| 0.5 | 3.0 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
| 0.5 | 2.5 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
| 0.5 | 2.0 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 0.5 | 35.8 | GO:0070206 | protein trimerization(GO:0070206) |
| 0.5 | 3.0 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.5 | 1.0 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.5 | 2.5 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.5 | 3.0 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
| 0.5 | 21.7 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.5 | 2.0 | GO:0072641 | type I interferon secretion(GO:0072641) |
| 0.5 | 1.0 | GO:0030035 | microspike assembly(GO:0030035) |
| 0.5 | 1.0 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
| 0.5 | 1.5 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 0.5 | 6.8 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
| 0.5 | 1.5 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
| 0.5 | 85.5 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
| 0.5 | 4.4 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.5 | 1.0 | GO:1902724 | positive regulation of skeletal muscle cell proliferation(GO:0014858) positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
| 0.5 | 3.4 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
| 0.5 | 9.2 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.5 | 1.4 | GO:0060382 | regulation of DNA strand elongation(GO:0060382) |
| 0.5 | 2.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.5 | 3.8 | GO:0009597 | detection of virus(GO:0009597) |
| 0.5 | 1.0 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
| 0.5 | 0.9 | GO:0031938 | regulation of chromatin silencing at telomere(GO:0031938) |
| 0.5 | 14.2 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.5 | 1.4 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
| 0.5 | 0.9 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.5 | 2.8 | GO:0015793 | glycerol transport(GO:0015793) |
| 0.5 | 2.4 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.5 | 4.7 | GO:0046104 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.5 | 1.4 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 0.5 | 3.3 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
| 0.5 | 0.5 | GO:0060876 | semicircular canal formation(GO:0060876) |
| 0.5 | 6.0 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.5 | 2.3 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
| 0.5 | 4.6 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
| 0.5 | 8.7 | GO:0017121 | phospholipid scrambling(GO:0017121) |
| 0.5 | 3.2 | GO:0006983 | ER overload response(GO:0006983) |
| 0.5 | 1.8 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
| 0.5 | 5.0 | GO:0000012 | single strand break repair(GO:0000012) |
| 0.5 | 2.3 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
| 0.5 | 2.3 | GO:2000813 | negative regulation of barbed-end actin filament capping(GO:2000813) |
| 0.5 | 2.3 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
| 0.5 | 1.4 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.4 | 3.6 | GO:0046836 | glycolipid transport(GO:0046836) |
| 0.4 | 2.2 | GO:0045047 | protein targeting to ER(GO:0045047) |
| 0.4 | 1.8 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 0.4 | 4.9 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
| 0.4 | 1.3 | GO:0045620 | negative regulation of lymphocyte differentiation(GO:0045620) |
| 0.4 | 2.2 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.4 | 2.7 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
| 0.4 | 3.0 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
| 0.4 | 3.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
| 0.4 | 3.0 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 0.4 | 3.5 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
| 0.4 | 1.3 | GO:0002372 | myeloid dendritic cell cytokine production(GO:0002372) |
| 0.4 | 0.4 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.4 | 0.9 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.4 | 12.5 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
| 0.4 | 10.7 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.4 | 90.9 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
| 0.4 | 6.8 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.4 | 3.8 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.4 | 2.6 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
| 0.4 | 1.3 | GO:1904717 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.4 | 1.3 | GO:0046080 | dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
| 0.4 | 7.2 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 0.4 | 0.4 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
| 0.4 | 9.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.4 | 0.8 | GO:0032202 | telomere assembly(GO:0032202) |
| 0.4 | 4.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.4 | 0.8 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 0.4 | 0.4 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
| 0.4 | 2.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.4 | 2.9 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.4 | 0.8 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 0.4 | 16.3 | GO:0031498 | chromatin disassembly(GO:0031498) |
| 0.4 | 2.9 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.4 | 3.3 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.4 | 2.9 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
| 0.4 | 8.6 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
| 0.4 | 9.0 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.4 | 1.2 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
| 0.4 | 0.4 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
| 0.4 | 4.1 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.4 | 2.8 | GO:0042832 | defense response to protozoan(GO:0042832) |
| 0.4 | 1.2 | GO:0090410 | malonate catabolic process(GO:0090410) |
| 0.4 | 1.6 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.4 | 3.2 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
| 0.4 | 1.6 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.4 | 1.2 | GO:1901078 | mastication(GO:0071626) learned vocalization behavior(GO:0098583) negative regulation of relaxation of muscle(GO:1901078) |
| 0.4 | 6.7 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.4 | 2.8 | GO:0015886 | heme transport(GO:0015886) |
| 0.4 | 1.2 | GO:0070054 | mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
| 0.4 | 0.8 | GO:0021511 | spinal cord patterning(GO:0021511) |
| 0.4 | 7.5 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.4 | 1.6 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
| 0.4 | 2.0 | GO:0043247 | telomere maintenance in response to DNA damage(GO:0043247) |
| 0.4 | 1.2 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
| 0.4 | 23.7 | GO:0035722 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
| 0.4 | 0.4 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 0.4 | 2.7 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.4 | 5.0 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.4 | 3.4 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.4 | 0.4 | GO:0051595 | response to methylglyoxal(GO:0051595) |
| 0.4 | 0.4 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
| 0.4 | 0.8 | GO:0042335 | cuticle development(GO:0042335) |
| 0.4 | 2.3 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
| 0.4 | 6.1 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
| 0.4 | 4.6 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.4 | 1.5 | GO:0035624 | receptor transactivation(GO:0035624) |
| 0.4 | 14.8 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
| 0.4 | 3.8 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.4 | 4.5 | GO:0010818 | T cell chemotaxis(GO:0010818) |
| 0.4 | 0.8 | GO:0060066 | oviduct development(GO:0060066) |
| 0.4 | 0.8 | GO:0032571 | response to vitamin K(GO:0032571) |
| 0.4 | 4.5 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.4 | 1.1 | GO:1905204 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) regulation of connective tissue replacement(GO:1905203) negative regulation of connective tissue replacement(GO:1905204) |
| 0.4 | 1.5 | GO:1902963 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
| 0.4 | 2.2 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.4 | 2.2 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
| 0.4 | 3.3 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
| 0.4 | 22.9 | GO:0002223 | stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
| 0.4 | 4.8 | GO:0030091 | protein repair(GO:0030091) |
| 0.4 | 5.5 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.4 | 2.6 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.4 | 3.7 | GO:0050868 | negative regulation of T cell activation(GO:0050868) |
| 0.4 | 1.5 | GO:2001020 | regulation of response to DNA damage stimulus(GO:2001020) |
| 0.4 | 5.5 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
| 0.4 | 4.0 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.4 | 2.6 | GO:0051023 | regulation of immunoglobulin secretion(GO:0051023) |
| 0.4 | 1.8 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
| 0.4 | 5.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.4 | 8.7 | GO:0043029 | T cell homeostasis(GO:0043029) |
| 0.4 | 2.5 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.4 | 1.8 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 0.4 | 4.7 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
| 0.4 | 1.4 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.4 | 1.8 | GO:0034205 | beta-amyloid formation(GO:0034205) |
| 0.4 | 1.4 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
| 0.4 | 3.6 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.4 | 1.4 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
| 0.4 | 1.1 | GO:0070874 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.4 | 0.7 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 0.4 | 2.8 | GO:0045007 | depurination(GO:0045007) |
| 0.4 | 1.4 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
| 0.4 | 15.1 | GO:0050688 | regulation of defense response to virus(GO:0050688) |
| 0.3 | 3.5 | GO:2000045 | regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
| 0.3 | 11.9 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.3 | 1.0 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
| 0.3 | 2.4 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 0.3 | 4.5 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.3 | 2.4 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.3 | 0.3 | GO:0001743 | optic placode formation(GO:0001743) |
| 0.3 | 3.1 | GO:0034214 | protein hexamerization(GO:0034214) |
| 0.3 | 0.7 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
| 0.3 | 4.4 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
| 0.3 | 2.0 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
| 0.3 | 3.1 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
| 0.3 | 1.7 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 0.3 | 3.0 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.3 | 1.0 | GO:0072675 | osteoclast fusion(GO:0072675) |
| 0.3 | 1.4 | GO:1905229 | cellular response to glycoprotein(GO:1904588) cellular response to thyrotropin-releasing hormone(GO:1905229) |
| 0.3 | 6.1 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
| 0.3 | 0.3 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
| 0.3 | 1.0 | GO:0070145 | mitochondrial asparaginyl-tRNA aminoacylation(GO:0070145) |
| 0.3 | 4.0 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
| 0.3 | 10.4 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.3 | 7.3 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
| 0.3 | 1.3 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.3 | 0.3 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.3 | 1.0 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.3 | 2.3 | GO:0043144 | snoRNA processing(GO:0043144) |
| 0.3 | 0.3 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.3 | 2.0 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.3 | 1.6 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
| 0.3 | 7.5 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.3 | 3.3 | GO:0042094 | interleukin-2 biosynthetic process(GO:0042094) |
| 0.3 | 4.5 | GO:0033753 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
| 0.3 | 1.3 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 0.3 | 2.9 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.3 | 5.1 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
| 0.3 | 1.0 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.3 | 3.5 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.3 | 2.9 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.3 | 0.3 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
| 0.3 | 9.5 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.3 | 0.3 | GO:2000157 | negative regulation of protein deubiquitination(GO:0090086) regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) regulation of ubiquitin-specific protease activity(GO:2000152) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.3 | 1.0 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
| 0.3 | 1.9 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
| 0.3 | 0.3 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.3 | 7.2 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 0.3 | 1.6 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
| 0.3 | 4.6 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 0.3 | 7.4 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.3 | 0.9 | GO:0009644 | response to high light intensity(GO:0009644) |
| 0.3 | 1.2 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.3 | 0.3 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
| 0.3 | 2.8 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.3 | 0.9 | GO:0002769 | natural killer cell inhibitory signaling pathway(GO:0002769) |
| 0.3 | 0.3 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.3 | 3.0 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.3 | 5.5 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
| 0.3 | 19.9 | GO:0050672 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
| 0.3 | 3.6 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.3 | 10.4 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
| 0.3 | 0.9 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.3 | 1.8 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
| 0.3 | 0.9 | GO:0061042 | vascular wound healing(GO:0061042) |
| 0.3 | 1.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.3 | 2.1 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
| 0.3 | 1.2 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
| 0.3 | 3.8 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.3 | 1.5 | GO:0001865 | NK T cell differentiation(GO:0001865) |
| 0.3 | 1.5 | GO:0070231 | T cell apoptotic process(GO:0070231) |
| 0.3 | 0.9 | GO:0002676 | regulation of chronic inflammatory response(GO:0002676) |
| 0.3 | 0.9 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
| 0.3 | 0.6 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.3 | 3.4 | GO:0031935 | regulation of chromatin silencing(GO:0031935) |
| 0.3 | 2.9 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.3 | 3.2 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.3 | 0.9 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.3 | 1.1 | GO:0009405 | pathogenesis(GO:0009405) |
| 0.3 | 4.0 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
| 0.3 | 8.0 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.3 | 2.3 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) |
| 0.3 | 1.7 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.3 | 19.2 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.3 | 2.0 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
| 0.3 | 4.8 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
| 0.3 | 1.1 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.3 | 3.7 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.3 | 0.3 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.3 | 2.5 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.3 | 1.4 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.3 | 6.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.3 | 3.9 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.3 | 0.8 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
| 0.3 | 3.0 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.3 | 3.6 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.3 | 0.8 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
| 0.3 | 0.5 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
| 0.3 | 2.7 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.3 | 7.6 | GO:0006363 | transcription initiation from RNA polymerase I promoter(GO:0006361) termination of RNA polymerase I transcription(GO:0006363) |
| 0.3 | 0.3 | GO:0021861 | forebrain radial glial cell differentiation(GO:0021861) |
| 0.3 | 1.9 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
| 0.3 | 5.4 | GO:0009303 | rRNA transcription(GO:0009303) |
| 0.3 | 4.3 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.3 | 10.4 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
| 0.3 | 12.5 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
| 0.3 | 0.5 | GO:0009149 | pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
| 0.3 | 0.8 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
| 0.3 | 0.8 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.3 | 0.5 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.3 | 0.5 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
| 0.3 | 2.4 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
| 0.3 | 3.7 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.3 | 1.6 | GO:0048821 | erythrocyte development(GO:0048821) |
| 0.3 | 27.3 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.3 | 3.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.3 | 4.4 | GO:1900180 | regulation of protein localization to nucleus(GO:1900180) |
| 0.3 | 1.3 | GO:0036233 | glycine import(GO:0036233) |
| 0.3 | 15.1 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) |
| 0.3 | 7.4 | GO:0007077 | mitotic nuclear envelope disassembly(GO:0007077) |
| 0.3 | 1.3 | GO:0051383 | kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
| 0.3 | 1.8 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 0.3 | 0.8 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.3 | 1.0 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.3 | 11.2 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
| 0.3 | 3.3 | GO:0019835 | cytolysis(GO:0019835) |
| 0.3 | 0.5 | GO:0072711 | cellular response to hydroxyurea(GO:0072711) |
| 0.2 | 4.5 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.2 | 4.5 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.2 | 2.0 | GO:0042940 | D-amino acid transport(GO:0042940) |
| 0.2 | 11.7 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.2 | 4.9 | GO:0043578 | nuclear matrix organization(GO:0043578) |
| 0.2 | 3.9 | GO:0098969 | neurotransmitter receptor transport to postsynaptic membrane(GO:0098969) establishment of protein localization to postsynaptic membrane(GO:1903540) |
| 0.2 | 4.4 | GO:0032625 | interleukin-21 production(GO:0032625) T follicular helper cell differentiation(GO:0061470) interleukin-21 secretion(GO:0072619) |
| 0.2 | 4.4 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
| 0.2 | 0.7 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
| 0.2 | 1.0 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
| 0.2 | 1.4 | GO:0010157 | response to chlorate(GO:0010157) |
| 0.2 | 8.4 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.2 | 3.8 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.2 | 19.4 | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
| 0.2 | 0.2 | GO:0008355 | olfactory learning(GO:0008355) |
| 0.2 | 5.0 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
| 0.2 | 6.4 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.2 | 1.9 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.2 | 4.3 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.2 | 0.7 | GO:0072520 | seminiferous tubule development(GO:0072520) |
| 0.2 | 0.9 | GO:0052651 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.2 | 0.9 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
| 0.2 | 0.9 | GO:2000611 | thyroid-stimulating hormone signaling pathway(GO:0038194) positive regulation of thyroid hormone generation(GO:2000611) |
| 0.2 | 7.7 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
| 0.2 | 0.9 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
| 0.2 | 0.9 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.2 | 0.7 | GO:0036093 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
| 0.2 | 0.9 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 0.2 | 0.9 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.2 | 2.0 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
| 0.2 | 0.7 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
| 0.2 | 1.1 | GO:0046072 | dUDP biosynthetic process(GO:0006227) dTDP biosynthetic process(GO:0006233) pyrimidine nucleoside diphosphate metabolic process(GO:0009138) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dTDP metabolic process(GO:0046072) dUDP metabolic process(GO:0046077) |
| 0.2 | 1.6 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.2 | 1.8 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.2 | 1.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.2 | 2.5 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.2 | 1.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.2 | 0.9 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 0.2 | 0.4 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) positive regulation of arachidonic acid secretion(GO:0090238) |
| 0.2 | 0.7 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
| 0.2 | 10.0 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.2 | 15.3 | GO:1902108 | regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902108) |
| 0.2 | 0.7 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
| 0.2 | 0.4 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
| 0.2 | 0.2 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
| 0.2 | 0.4 | GO:0032351 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) negative regulation of hormone metabolic process(GO:0032351) negative regulation of hormone biosynthetic process(GO:0032353) negative regulation of steroid hormone biosynthetic process(GO:0090032) |
| 0.2 | 12.6 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.2 | 0.2 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
| 0.2 | 2.0 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
| 0.2 | 1.3 | GO:0050685 | positive regulation of mRNA processing(GO:0050685) |
| 0.2 | 9.3 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
| 0.2 | 1.5 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
| 0.2 | 8.8 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
| 0.2 | 0.6 | GO:0035963 | cellular response to interleukin-13(GO:0035963) |
| 0.2 | 0.6 | GO:0090222 | centrosome-templated microtubule nucleation(GO:0090222) |
| 0.2 | 0.9 | GO:0061358 | negative regulation of Wnt protein secretion(GO:0061358) |
| 0.2 | 2.8 | GO:0046548 | retinal rod cell development(GO:0046548) |
| 0.2 | 1.5 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
| 0.2 | 3.6 | GO:0015816 | glycine transport(GO:0015816) |
| 0.2 | 4.0 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.2 | 3.1 | GO:0045713 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) |
| 0.2 | 2.1 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
| 0.2 | 1.2 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.2 | 0.8 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
| 0.2 | 2.5 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
| 0.2 | 1.2 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
| 0.2 | 1.7 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
| 0.2 | 1.2 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
| 0.2 | 2.7 | GO:0060992 | response to fungicide(GO:0060992) |
| 0.2 | 1.0 | GO:0046469 | platelet activating factor metabolic process(GO:0046469) |
| 0.2 | 0.8 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
| 0.2 | 1.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 0.2 | 0.4 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.2 | 9.0 | GO:0006305 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
| 0.2 | 1.2 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
| 0.2 | 1.4 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.2 | 2.0 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
| 0.2 | 0.8 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
| 0.2 | 1.0 | GO:1902559 | 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
| 0.2 | 2.0 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.2 | 0.4 | GO:0035794 | positive regulation of mitochondrial membrane permeability(GO:0035794) |
| 0.2 | 3.8 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
| 0.2 | 0.8 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.2 | 0.6 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.2 | 1.0 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.2 | 3.2 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.2 | 1.0 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.2 | 3.9 | GO:0034204 | lipid translocation(GO:0034204) |
| 0.2 | 0.2 | GO:0006867 | asparagine transport(GO:0006867) |
| 0.2 | 0.8 | GO:0060023 | soft palate development(GO:0060023) |
| 0.2 | 3.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.2 | 1.9 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.2 | 0.2 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.2 | 0.6 | GO:0021764 | amygdala development(GO:0021764) |
| 0.2 | 1.0 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.2 | 2.1 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.2 | 1.1 | GO:0001507 | acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) |
| 0.2 | 2.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.2 | 1.7 | GO:0060613 | fat pad development(GO:0060613) |
| 0.2 | 2.7 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
| 0.2 | 1.3 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.2 | 0.9 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
| 0.2 | 0.9 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
| 0.2 | 3.2 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
| 0.2 | 13.5 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.2 | 2.4 | GO:0097324 | melanocyte migration(GO:0097324) positive regulation of lens fiber cell differentiation(GO:1902748) |
| 0.2 | 0.8 | GO:0030581 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.2 | 0.9 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.2 | 1.1 | GO:0009211 | pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) |
| 0.2 | 1.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
| 0.2 | 5.4 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
| 0.2 | 0.6 | GO:1905216 | regulation of RNA binding(GO:1905214) positive regulation of RNA binding(GO:1905216) |
| 0.2 | 0.4 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.2 | 0.9 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 0.2 | 0.7 | GO:0002360 | T cell lineage commitment(GO:0002360) |
| 0.2 | 0.4 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.2 | 1.6 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
| 0.2 | 7.6 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
| 0.2 | 21.7 | GO:0051028 | mRNA transport(GO:0051028) |
| 0.2 | 0.4 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) |
| 0.2 | 0.9 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 0.2 | 1.4 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.2 | 1.3 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
| 0.2 | 2.1 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
| 0.2 | 0.9 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
| 0.2 | 5.5 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
| 0.2 | 1.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
| 0.2 | 1.1 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.2 | 1.6 | GO:0002347 | response to tumor cell(GO:0002347) |
| 0.2 | 4.1 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
| 0.2 | 0.3 | GO:0048254 | snoRNA localization(GO:0048254) |
| 0.2 | 1.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.2 | 0.3 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
| 0.2 | 0.2 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.2 | 1.4 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.2 | 5.7 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
| 0.2 | 1.7 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
| 0.2 | 0.2 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.2 | 2.7 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
| 0.2 | 0.3 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
| 0.2 | 0.5 | GO:0061009 | common bile duct development(GO:0061009) |
| 0.2 | 2.2 | GO:0006188 | IMP biosynthetic process(GO:0006188) |
| 0.2 | 0.7 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
| 0.2 | 1.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.2 | 2.7 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.2 | 1.7 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
| 0.2 | 6.6 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
| 0.2 | 1.7 | GO:0055070 | copper ion homeostasis(GO:0055070) |
| 0.2 | 1.3 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.2 | 0.5 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.2 | 13.0 | GO:0008033 | tRNA processing(GO:0008033) |
| 0.2 | 0.8 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.2 | 0.3 | GO:0031296 | B cell costimulation(GO:0031296) |
| 0.2 | 12.4 | GO:0070527 | platelet aggregation(GO:0070527) |
| 0.2 | 1.8 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.2 | 0.8 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
| 0.2 | 0.2 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.2 | 6.1 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
| 0.2 | 0.6 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
| 0.2 | 2.4 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
| 0.2 | 6.9 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.2 | 0.3 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
| 0.2 | 0.9 | GO:0016574 | histone ubiquitination(GO:0016574) |
| 0.2 | 2.5 | GO:0009299 | mRNA transcription(GO:0009299) |
| 0.2 | 0.6 | GO:0048535 | lymph node development(GO:0048535) |
| 0.2 | 1.7 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
| 0.2 | 0.9 | GO:0002507 | tolerance induction(GO:0002507) |
| 0.2 | 1.5 | GO:0008340 | determination of adult lifespan(GO:0008340) |
| 0.2 | 1.2 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
| 0.2 | 2.3 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
| 0.2 | 5.0 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.2 | 4.9 | GO:0001696 | gastric acid secretion(GO:0001696) |
| 0.2 | 0.3 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.2 | 6.8 | GO:0034728 | nucleosome organization(GO:0034728) |
| 0.2 | 1.5 | GO:0007143 | female meiotic division(GO:0007143) |
| 0.2 | 7.1 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
| 0.2 | 0.2 | GO:1900625 | monocyte aggregation(GO:0070487) regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.2 | 0.5 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
| 0.1 | 2.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
| 0.1 | 1.2 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 0.1 | 1.5 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.1 | 0.3 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
| 0.1 | 2.9 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
| 0.1 | 0.4 | GO:0051983 | regulation of chromosome segregation(GO:0051983) |
| 0.1 | 0.9 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
| 0.1 | 4.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.1 | 1.4 | GO:0038066 | p38MAPK cascade(GO:0038066) |
| 0.1 | 4.9 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
| 0.1 | 3.0 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.1 | 2.6 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.1 | 1.9 | GO:0000018 | regulation of DNA recombination(GO:0000018) |
| 0.1 | 0.4 | GO:0090156 | cellular sphingolipid homeostasis(GO:0090156) |
| 0.1 | 2.7 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
| 0.1 | 6.9 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.1 | 8.8 | GO:0007032 | endosome organization(GO:0007032) |
| 0.1 | 4.3 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
| 0.1 | 0.4 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
| 0.1 | 0.3 | GO:0035262 | gonad morphogenesis(GO:0035262) |
| 0.1 | 1.4 | GO:0048286 | lung alveolus development(GO:0048286) |
| 0.1 | 0.8 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.1 | 1.1 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
| 0.1 | 1.4 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
| 0.1 | 1.1 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.1 | 0.3 | GO:1903576 | response to L-arginine(GO:1903576) |
| 0.1 | 1.5 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
| 0.1 | 0.5 | GO:0038093 | Fc receptor signaling pathway(GO:0038093) |
| 0.1 | 0.7 | GO:0034036 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.1 | 3.9 | GO:0051642 | centrosome localization(GO:0051642) |
| 0.1 | 0.4 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.1 | 1.2 | GO:1902572 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.1 | 1.2 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
| 0.1 | 1.6 | GO:0032506 | cytokinetic process(GO:0032506) |
| 0.1 | 0.1 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
| 0.1 | 2.2 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
| 0.1 | 4.6 | GO:0097352 | autophagosome maturation(GO:0097352) |
| 0.1 | 1.0 | GO:0006513 | protein monoubiquitination(GO:0006513) |
| 0.1 | 0.6 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.1 | 1.5 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.1 | 3.0 | GO:0072676 | lymphocyte migration(GO:0072676) |
| 0.1 | 2.8 | GO:0030225 | macrophage differentiation(GO:0030225) |
| 0.1 | 0.1 | GO:0060068 | vagina development(GO:0060068) |
| 0.1 | 2.3 | GO:0006284 | base-excision repair(GO:0006284) |
| 0.1 | 0.4 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.1 | 1.3 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
| 0.1 | 0.5 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
| 0.1 | 0.4 | GO:0060939 | cardiac fibroblast cell differentiation(GO:0060935) cardiac fibroblast cell development(GO:0060936) epicardium-derived cardiac fibroblast cell differentiation(GO:0060938) epicardium-derived cardiac fibroblast cell development(GO:0060939) |
| 0.1 | 0.8 | GO:0040038 | polar body extrusion after meiotic divisions(GO:0040038) |
| 0.1 | 0.8 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
| 0.1 | 1.0 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
| 0.1 | 0.7 | GO:0019080 | viral gene expression(GO:0019080) |
| 0.1 | 0.8 | GO:1902692 | regulation of neuroblast proliferation(GO:1902692) |
| 0.1 | 1.6 | GO:0050931 | melanocyte differentiation(GO:0030318) pigment cell differentiation(GO:0050931) |
| 0.1 | 0.5 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.1 | 0.5 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
| 0.1 | 0.7 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
| 0.1 | 1.2 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.1 | 0.5 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
| 0.1 | 1.5 | GO:0006298 | mismatch repair(GO:0006298) |
| 0.1 | 8.3 | GO:0051607 | defense response to virus(GO:0051607) |
| 0.1 | 0.2 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
| 0.1 | 0.6 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.1 | 0.4 | GO:0018343 | protein farnesylation(GO:0018343) |
| 0.1 | 1.3 | GO:0035196 | production of miRNAs involved in gene silencing by miRNA(GO:0035196) |
| 0.1 | 0.3 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
| 0.1 | 1.6 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
| 0.1 | 0.2 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
| 0.1 | 0.2 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
| 0.1 | 0.8 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
| 0.1 | 1.9 | GO:0019985 | translesion synthesis(GO:0019985) |
| 0.1 | 0.2 | GO:2000858 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
| 0.1 | 1.0 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.1 | 2.6 | GO:0030183 | B cell differentiation(GO:0030183) |
| 0.1 | 0.2 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
| 0.1 | 8.4 | GO:0006413 | translational initiation(GO:0006413) |
| 0.1 | 1.3 | GO:0014029 | neural crest formation(GO:0014029) |
| 0.1 | 0.5 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.1 | 0.3 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.1 | 1.6 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
| 0.1 | 2.9 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
| 0.1 | 8.0 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 0.1 | 0.6 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
| 0.1 | 0.2 | GO:0007442 | hindgut morphogenesis(GO:0007442) |
| 0.1 | 1.0 | GO:0045005 | replication fork processing(GO:0031297) DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
| 0.1 | 2.5 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.1 | 0.8 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) establishment of protein localization to mitochondrial membrane(GO:0090151) |
| 0.1 | 0.3 | GO:0030974 | thiamine pyrophosphate transport(GO:0030974) |
| 0.1 | 1.7 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.1 | 0.7 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.1 | 0.4 | GO:1900148 | Schwann cell proliferation involved in axon regeneration(GO:0014011) Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
| 0.1 | 0.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.1 | 0.7 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
| 0.1 | 2.8 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
| 0.1 | 2.2 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
| 0.1 | 4.9 | GO:0002224 | toll-like receptor signaling pathway(GO:0002224) |
| 0.1 | 0.8 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.1 | 1.4 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.1 | 1.9 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.1 | 2.3 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.1 | 0.4 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.1 | 1.9 | GO:0002115 | store-operated calcium entry(GO:0002115) |
| 0.1 | 0.4 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.1 | 0.7 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
| 0.1 | 2.8 | GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity(GO:0043433) |
| 0.1 | 0.5 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.1 | 0.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 | 0.5 | GO:0006828 | manganese ion transport(GO:0006828) |
| 0.1 | 0.5 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
| 0.1 | 0.7 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.1 | 0.5 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.1 | 1.3 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 | 1.2 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.1 | 0.2 | GO:0034111 | negative regulation of homotypic cell-cell adhesion(GO:0034111) |
| 0.1 | 0.5 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.1 | 0.4 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.1 | 0.5 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
| 0.1 | 0.9 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.1 | 0.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.1 | 1.9 | GO:0009309 | amine biosynthetic process(GO:0009309) |
| 0.1 | 5.3 | GO:0051225 | spindle assembly(GO:0051225) |
| 0.1 | 1.2 | GO:0060009 | Sertoli cell development(GO:0060009) |
| 0.1 | 1.5 | GO:0007035 | vacuolar acidification(GO:0007035) |
| 0.1 | 1.2 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.1 | 1.2 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
| 0.1 | 0.5 | GO:0070378 | positive regulation of ERK5 cascade(GO:0070378) |
| 0.1 | 1.8 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
| 0.1 | 0.3 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
| 0.1 | 0.2 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
| 0.1 | 4.6 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
| 0.1 | 0.2 | GO:0060967 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by RNA(GO:0060967) |
| 0.1 | 0.4 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
| 0.1 | 1.3 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.1 | 0.4 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
| 0.1 | 6.5 | GO:0050848 | regulation of calcium-mediated signaling(GO:0050848) |
| 0.1 | 5.1 | GO:0007030 | Golgi organization(GO:0007030) |
| 0.1 | 0.3 | GO:0010983 | regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
| 0.1 | 0.5 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.1 | 0.3 | GO:0045023 | G0 to G1 transition(GO:0045023) |
| 0.1 | 1.0 | GO:0045089 | positive regulation of innate immune response(GO:0045089) |
| 0.1 | 1.6 | GO:0001825 | blastocyst formation(GO:0001825) |
| 0.1 | 0.2 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 0.1 | 1.1 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
| 0.1 | 1.3 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
| 0.1 | 1.2 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
| 0.1 | 2.0 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
| 0.1 | 0.3 | GO:0016062 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
| 0.1 | 0.2 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.1 | 0.5 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
| 0.1 | 0.2 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
| 0.1 | 0.5 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
| 0.1 | 0.1 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
| 0.1 | 0.5 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
| 0.1 | 0.2 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
| 0.1 | 0.1 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) |
| 0.1 | 0.2 | GO:0003032 | detection of oxygen(GO:0003032) |
| 0.1 | 1.0 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.1 | 0.5 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 0.1 | 0.4 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
| 0.1 | 5.1 | GO:0042303 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
| 0.1 | 0.7 | GO:0072498 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
| 0.1 | 0.2 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
| 0.1 | 0.8 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
| 0.1 | 0.4 | GO:0043697 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.1 | 8.2 | GO:0006338 | chromatin remodeling(GO:0006338) |
| 0.1 | 0.5 | GO:0046618 | drug export(GO:0046618) |
| 0.1 | 0.5 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
| 0.1 | 0.6 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.1 | 0.4 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.1 | 1.4 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
| 0.1 | 2.0 | GO:0016573 | histone acetylation(GO:0016573) |
| 0.1 | 3.5 | GO:0043966 | histone H3 acetylation(GO:0043966) |
| 0.1 | 0.2 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.1 | 3.2 | GO:0046916 | cellular transition metal ion homeostasis(GO:0046916) |
| 0.1 | 0.2 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
| 0.1 | 0.2 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.1 | 0.3 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
| 0.1 | 0.1 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
| 0.1 | 0.4 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
| 0.1 | 0.5 | GO:0000732 | strand displacement(GO:0000732) |
| 0.1 | 0.5 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
| 0.1 | 1.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.1 | 0.8 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
| 0.1 | 1.4 | GO:0030033 | microvillus assembly(GO:0030033) |
| 0.1 | 0.3 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.1 | 0.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.1 | 1.1 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
| 0.1 | 0.3 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.1 | 2.3 | GO:0030098 | lymphocyte differentiation(GO:0030098) |
| 0.1 | 0.2 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.1 | 1.1 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
| 0.1 | 0.2 | GO:0060178 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
| 0.1 | 0.2 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 0.1 | 0.1 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
| 0.1 | 0.7 | GO:1902358 | oxalate transport(GO:0019532) sulfate transmembrane transport(GO:1902358) |
| 0.1 | 0.3 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
| 0.1 | 1.3 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.1 | 0.9 | GO:0035411 | catenin import into nucleus(GO:0035411) |
| 0.1 | 9.3 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) |
| 0.1 | 0.2 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.1 | 0.4 | GO:0060346 | bone trabecula formation(GO:0060346) |
| 0.1 | 0.6 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.1 | 0.8 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
| 0.1 | 1.0 | GO:0060606 | neural tube closure(GO:0001843) tube closure(GO:0060606) |
| 0.1 | 0.1 | GO:0030576 | Cajal body organization(GO:0030576) |
| 0.1 | 1.5 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
| 0.1 | 1.1 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) |
| 0.1 | 1.7 | GO:0043171 | peptide catabolic process(GO:0043171) |
| 0.1 | 0.2 | GO:0045337 | geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
| 0.1 | 2.2 | GO:0051646 | mitochondrion localization(GO:0051646) |
| 0.1 | 2.5 | GO:0001837 | epithelial to mesenchymal transition(GO:0001837) |
| 0.1 | 0.3 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
| 0.1 | 0.5 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.1 | 0.2 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
| 0.1 | 0.3 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
| 0.0 | 0.1 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.0 | 1.9 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
| 0.0 | 0.2 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 0.0 | 0.4 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
| 0.0 | 1.0 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
| 0.0 | 0.5 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.0 | 0.0 | GO:0060736 | prostate gland growth(GO:0060736) |
| 0.0 | 1.0 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
| 0.0 | 0.3 | GO:0032025 | response to cobalt ion(GO:0032025) |
| 0.0 | 0.1 | GO:0046877 | regulation of saliva secretion(GO:0046877) positive regulation of saliva secretion(GO:0046878) |
| 0.0 | 0.7 | GO:0060976 | coronary vasculature development(GO:0060976) |
| 0.0 | 0.3 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 0.0 | 0.8 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.0 | 2.6 | GO:0001895 | retina homeostasis(GO:0001895) |
| 0.0 | 0.1 | GO:0051029 | rRNA import into mitochondrion(GO:0035928) rRNA transport(GO:0051029) |
| 0.0 | 0.3 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) |
| 0.0 | 0.5 | GO:0009642 | response to light intensity(GO:0009642) |
| 0.0 | 0.5 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.0 | 0.2 | GO:0046599 | regulation of centriole replication(GO:0046599) |
| 0.0 | 0.2 | GO:1900115 | extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
| 0.0 | 3.2 | GO:0002250 | adaptive immune response(GO:0002250) |
| 0.0 | 0.6 | GO:0042113 | B cell activation(GO:0042113) |
| 0.0 | 0.3 | GO:0000050 | urea cycle(GO:0000050) |
| 0.0 | 0.2 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.0 | 0.1 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.0 | 0.3 | GO:0006304 | DNA modification(GO:0006304) |
| 0.0 | 0.2 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
| 0.0 | 0.7 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
| 0.0 | 2.0 | GO:0007602 | phototransduction(GO:0007602) |
| 0.0 | 0.1 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.0 | 0.0 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
| 0.0 | 0.1 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
| 0.0 | 0.2 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.0 | 0.9 | GO:0015893 | drug transport(GO:0015893) |
| 0.0 | 0.1 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
| 0.0 | 0.2 | GO:1902414 | protein localization to cell junction(GO:1902414) |
| 0.0 | 0.1 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
| 0.0 | 115.2 | GO:0097659 | nucleic acid-templated transcription(GO:0097659) |
| 0.0 | 0.1 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.0 | 0.4 | GO:0016925 | protein sumoylation(GO:0016925) |
| 0.0 | 0.6 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.0 | 0.8 | GO:0071539 | protein localization to centrosome(GO:0071539) |
| 0.0 | 1.9 | GO:0007050 | cell cycle arrest(GO:0007050) |
| 0.0 | 0.4 | GO:0038034 | signal transduction in absence of ligand(GO:0038034) extrinsic apoptotic signaling pathway in absence of ligand(GO:0097192) |
| 0.0 | 0.3 | GO:0009249 | protein lipoylation(GO:0009249) |
| 0.0 | 0.2 | GO:0097267 | omega-hydroxylase P450 pathway(GO:0097267) |
| 0.0 | 0.3 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.0 | 0.0 | GO:0010661 | positive regulation of muscle cell apoptotic process(GO:0010661) |
| 0.0 | 0.5 | GO:0000082 | G1/S transition of mitotic cell cycle(GO:0000082) |
| 0.0 | 0.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.0 | 0.0 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 0.0 | 0.9 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
| 0.0 | 0.1 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
| 0.0 | 0.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
| 0.0 | 0.2 | GO:0031123 | RNA 3'-end processing(GO:0031123) |
| 0.0 | 0.0 | GO:0044117 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
| 0.0 | 2.1 | GO:0018105 | peptidyl-serine phosphorylation(GO:0018105) |
| 0.0 | 0.6 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
| 0.0 | 0.8 | GO:1990823 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
| 0.0 | 0.3 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
| 0.0 | 0.1 | GO:0035148 | tube formation(GO:0035148) |
| 0.0 | 11.8 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
| 0.0 | 0.0 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
| 0.0 | 0.0 | GO:0035445 | borate transmembrane transport(GO:0035445) borate transport(GO:0046713) |
| 0.0 | 0.2 | GO:0010212 | response to ionizing radiation(GO:0010212) |
| 0.0 | 0.0 | GO:1900005 | regulation of serine-type endopeptidase activity(GO:1900003) positive regulation of serine-type endopeptidase activity(GO:1900005) regulation of serine-type peptidase activity(GO:1902571) positive regulation of serine-type peptidase activity(GO:1902573) |
| 0.0 | 0.1 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.6 | 4.6 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 4.3 | 21.4 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 4.2 | 12.5 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
| 3.7 | 44.6 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 3.4 | 34.2 | GO:0044194 | cytolytic granule(GO:0044194) |
| 3.4 | 27.3 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
| 2.6 | 20.7 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 2.6 | 10.3 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
| 2.5 | 7.6 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 2.5 | 7.4 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
| 2.5 | 12.3 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
| 2.4 | 24.2 | GO:0032010 | phagolysosome(GO:0032010) |
| 2.3 | 9.1 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
| 2.3 | 27.2 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 2.3 | 6.8 | GO:0044609 | DBIRD complex(GO:0044609) |
| 2.1 | 25.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 2.0 | 2.0 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 2.0 | 21.9 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
| 1.8 | 5.5 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
| 1.8 | 10.8 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 1.8 | 8.8 | GO:0071752 | dimeric IgA immunoglobulin complex(GO:0071750) secretory dimeric IgA immunoglobulin complex(GO:0071752) |
| 1.7 | 8.7 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 1.7 | 6.9 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 1.7 | 8.3 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 1.6 | 32.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 1.6 | 8.0 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
| 1.5 | 12.3 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 1.5 | 4.6 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 1.5 | 4.5 | GO:0032998 | Fc receptor complex(GO:0032997) Fc-epsilon receptor I complex(GO:0032998) |
| 1.5 | 40.0 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 1.5 | 14.7 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 1.5 | 7.3 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
| 1.4 | 27.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 1.4 | 24.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 1.4 | 37.1 | GO:0097342 | ripoptosome(GO:0097342) |
| 1.4 | 1.4 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 1.4 | 2.8 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 1.4 | 4.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
| 1.4 | 8.2 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 1.3 | 14.7 | GO:0071986 | Ragulator complex(GO:0071986) |
| 1.3 | 1.3 | GO:0042587 | glycogen granule(GO:0042587) |
| 1.3 | 8.0 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
| 1.3 | 10.6 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
| 1.3 | 3.9 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
| 1.3 | 3.8 | GO:0032116 | SMC loading complex(GO:0032116) |
| 1.3 | 101.8 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 1.3 | 3.8 | GO:0030526 | granulocyte macrophage colony-stimulating factor receptor complex(GO:0030526) |
| 1.3 | 1.3 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
| 1.3 | 143.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 1.2 | 8.5 | GO:0089701 | U2AF(GO:0089701) |
| 1.2 | 7.2 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
| 1.2 | 4.7 | GO:0035101 | FACT complex(GO:0035101) |
| 1.1 | 16.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 1.1 | 3.4 | GO:0016590 | ACF complex(GO:0016590) |
| 1.1 | 9.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 1.1 | 26.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 1.1 | 3.3 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 1.1 | 11.8 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
| 1.1 | 5.4 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
| 1.1 | 7.5 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 1.1 | 3.2 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
| 1.1 | 7.4 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 1.1 | 2.1 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 1.1 | 7.4 | GO:1990031 | pinceau fiber(GO:1990031) |
| 1.1 | 7.4 | GO:0070545 | PeBoW complex(GO:0070545) |
| 1.0 | 1.0 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 1.0 | 3.1 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
| 1.0 | 10.4 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 1.0 | 2.1 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
| 1.0 | 18.9 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 1.0 | 9.9 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 1.0 | 4.9 | GO:0005687 | U4 snRNP(GO:0005687) |
| 1.0 | 7.8 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 1.0 | 5.8 | GO:0000799 | nuclear condensin complex(GO:0000799) |
| 1.0 | 2.9 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 1.0 | 15.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.9 | 153.4 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.9 | 108.8 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.9 | 3.7 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
| 0.9 | 1.8 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
| 0.9 | 6.3 | GO:0031523 | Myb complex(GO:0031523) |
| 0.9 | 21.4 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.9 | 6.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.9 | 2.7 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.9 | 6.9 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.9 | 5.2 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
| 0.9 | 4.3 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 0.9 | 1.7 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.9 | 15.4 | GO:0032039 | integrator complex(GO:0032039) |
| 0.9 | 32.4 | GO:0032040 | small-subunit processome(GO:0032040) |
| 0.8 | 5.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.8 | 30.4 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.8 | 2.5 | GO:0000814 | ESCRT II complex(GO:0000814) |
| 0.8 | 2.5 | GO:0099400 | cytoplasmic side of mitochondrial outer membrane(GO:0032473) caveola neck(GO:0099400) |
| 0.8 | 69.7 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.8 | 13.4 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.8 | 2.5 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.8 | 32.4 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.8 | 5.8 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 0.8 | 5.7 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 0.8 | 50.0 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.8 | 5.7 | GO:0071942 | XPC complex(GO:0071942) |
| 0.8 | 4.9 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.8 | 3.2 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
| 0.8 | 9.6 | GO:0060171 | stereocilium membrane(GO:0060171) |
| 0.8 | 2.4 | GO:0000805 | X chromosome(GO:0000805) |
| 0.8 | 5.6 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.8 | 0.8 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.8 | 2.3 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
| 0.8 | 3.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
| 0.8 | 3.0 | GO:0070578 | RISC-loading complex(GO:0070578) |
| 0.7 | 12.6 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.7 | 5.9 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.7 | 8.1 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.7 | 1.4 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
| 0.7 | 5.1 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.7 | 1.4 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 0.7 | 14.7 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
| 0.7 | 14.0 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.7 | 5.6 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.7 | 13.2 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
| 0.7 | 5.5 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.7 | 2.8 | GO:1990879 | CST complex(GO:1990879) |
| 0.7 | 9.0 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.7 | 3.4 | GO:0036501 | UFD1-NPL4 complex(GO:0036501) |
| 0.7 | 4.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.7 | 4.1 | GO:0071797 | LUBAC complex(GO:0071797) |
| 0.7 | 15.5 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.7 | 18.6 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.7 | 11.9 | GO:0099738 | cell cortex region(GO:0099738) |
| 0.7 | 3.9 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.7 | 3.3 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.7 | 13.7 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.7 | 2.6 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.6 | 2.6 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
| 0.6 | 1.9 | GO:0042565 | RNA nuclear export complex(GO:0042565) |
| 0.6 | 5.6 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.6 | 1.9 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
| 0.6 | 11.7 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.6 | 11.7 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.6 | 6.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.6 | 11.0 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
| 0.6 | 5.5 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
| 0.6 | 5.4 | GO:0097413 | Lewy body(GO:0097413) |
| 0.6 | 4.7 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.6 | 49.5 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.6 | 10.4 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.6 | 6.9 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.6 | 11.5 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.6 | 2.3 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
| 0.6 | 4.0 | GO:1990462 | omegasome(GO:1990462) |
| 0.6 | 8.9 | GO:0090543 | Flemming body(GO:0090543) |
| 0.6 | 6.7 | GO:0071203 | WASH complex(GO:0071203) |
| 0.6 | 13.3 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.6 | 3.9 | GO:0032009 | early phagosome(GO:0032009) |
| 0.5 | 5.9 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.5 | 1.6 | GO:0018444 | translation release factor complex(GO:0018444) |
| 0.5 | 12.1 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.5 | 5.3 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.5 | 4.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
| 0.5 | 3.6 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 0.5 | 1.5 | GO:1902636 | kinociliary basal body(GO:1902636) |
| 0.5 | 2.0 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.5 | 2.5 | GO:0005638 | lamin filament(GO:0005638) |
| 0.5 | 7.5 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
| 0.5 | 3.0 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.5 | 15.8 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 0.5 | 3.4 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.5 | 1.5 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
| 0.5 | 2.0 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
| 0.5 | 7.8 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.5 | 1.0 | GO:0008623 | CHRAC(GO:0008623) |
| 0.5 | 10.1 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
| 0.5 | 44.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.5 | 0.5 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.5 | 4.3 | GO:0001940 | male pronucleus(GO:0001940) |
| 0.5 | 1.9 | GO:0001652 | granular component(GO:0001652) |
| 0.5 | 1.9 | GO:0000502 | proteasome complex(GO:0000502) |
| 0.5 | 6.6 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.5 | 8.9 | GO:0097451 | glial limiting end-foot(GO:0097451) |
| 0.5 | 4.7 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
| 0.5 | 1.4 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
| 0.5 | 3.7 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.5 | 6.5 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.5 | 0.9 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
| 0.5 | 1.4 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
| 0.5 | 9.1 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.5 | 3.2 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 0.5 | 5.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.5 | 51.9 | GO:0005776 | autophagosome(GO:0005776) |
| 0.4 | 2.7 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.4 | 8.9 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.4 | 2.2 | GO:0042599 | lamellar body(GO:0042599) |
| 0.4 | 1.3 | GO:0097462 | glial cytoplasmic inclusion(GO:0097409) classical Lewy body(GO:0097414) Lewy neurite(GO:0097462) Lewy body corona(GO:1990038) |
| 0.4 | 7.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.4 | 3.5 | GO:0032021 | NELF complex(GO:0032021) |
| 0.4 | 7.0 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.4 | 9.6 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 0.4 | 2.2 | GO:0035363 | histone locus body(GO:0035363) |
| 0.4 | 27.4 | GO:0090544 | BAF-type complex(GO:0090544) |
| 0.4 | 13.2 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.4 | 1.3 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
| 0.4 | 1.2 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.4 | 4.1 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
| 0.4 | 5.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.4 | 0.4 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 0.4 | 9.8 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.4 | 13.8 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.4 | 49.2 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
| 0.4 | 1.6 | GO:0043293 | apoptosome(GO:0043293) |
| 0.4 | 0.4 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
| 0.4 | 9.7 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.4 | 3.2 | GO:0042588 | zymogen granule(GO:0042588) |
| 0.4 | 1.2 | GO:0031251 | PAN complex(GO:0031251) |
| 0.4 | 12.7 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
| 0.4 | 1.2 | GO:1990332 | Ire1 complex(GO:1990332) |
| 0.4 | 0.8 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.4 | 1.2 | GO:0001674 | female germ cell nucleus(GO:0001674) |
| 0.4 | 18.9 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.4 | 61.0 | GO:0016605 | PML body(GO:0016605) |
| 0.4 | 3.8 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
| 0.4 | 7.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.4 | 2.7 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
| 0.4 | 1.5 | GO:0035517 | PR-DUB complex(GO:0035517) |
| 0.4 | 10.6 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.4 | 7.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.4 | 1.9 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.4 | 32.1 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.4 | 4.1 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
| 0.4 | 12.6 | GO:0005719 | nuclear euchromatin(GO:0005719) |
| 0.4 | 2.2 | GO:0035339 | SPOTS complex(GO:0035339) |
| 0.4 | 1.1 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
| 0.4 | 4.7 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
| 0.4 | 3.6 | GO:0000974 | Prp19 complex(GO:0000974) |
| 0.4 | 3.2 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.4 | 1.4 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
| 0.4 | 0.7 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
| 0.4 | 1.4 | GO:0032798 | Swi5-Sfr1 complex(GO:0032798) |
| 0.4 | 1.1 | GO:0055087 | Ski complex(GO:0055087) |
| 0.3 | 1.7 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.3 | 1.0 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
| 0.3 | 1.7 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
| 0.3 | 2.4 | GO:0030891 | VCB complex(GO:0030891) |
| 0.3 | 0.7 | GO:1990423 | RZZ complex(GO:1990423) |
| 0.3 | 4.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.3 | 5.4 | GO:0097433 | dense body(GO:0097433) |
| 0.3 | 5.4 | GO:0071438 | invadopodium membrane(GO:0071438) |
| 0.3 | 1.7 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
| 0.3 | 6.0 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.3 | 35.9 | GO:0070820 | tertiary granule(GO:0070820) |
| 0.3 | 3.0 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 0.3 | 2.9 | GO:0098536 | deuterosome(GO:0098536) |
| 0.3 | 1.0 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.3 | 3.6 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.3 | 2.3 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
| 0.3 | 17.2 | GO:0042571 | immunoglobulin complex(GO:0019814) immunoglobulin complex, circulating(GO:0042571) |
| 0.3 | 4.5 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.3 | 1.9 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
| 0.3 | 21.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.3 | 15.9 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.3 | 5.3 | GO:0036452 | ESCRT complex(GO:0036452) |
| 0.3 | 1.2 | GO:0031082 | BLOC complex(GO:0031082) |
| 0.3 | 5.8 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 0.3 | 7.3 | GO:0036020 | endolysosome membrane(GO:0036020) |
| 0.3 | 50.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.3 | 17.1 | GO:0016592 | mediator complex(GO:0016592) |
| 0.3 | 2.4 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.3 | 4.2 | GO:0000812 | Swr1 complex(GO:0000812) |
| 0.3 | 8.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.3 | 1.5 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.3 | 1.2 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
| 0.3 | 5.8 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.3 | 1.2 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
| 0.3 | 14.7 | GO:0015030 | Cajal body(GO:0015030) |
| 0.3 | 12.9 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.3 | 1.4 | GO:0070187 | telosome(GO:0070187) |
| 0.3 | 1.7 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.3 | 1.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 0.3 | 19.4 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.3 | 1.4 | GO:0070822 | Sin3-type complex(GO:0070822) |
| 0.3 | 0.6 | GO:0000125 | PCAF complex(GO:0000125) |
| 0.3 | 0.6 | GO:0030430 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
| 0.3 | 4.4 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
| 0.3 | 33.4 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.3 | 0.8 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.3 | 17.9 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.3 | 9.4 | GO:1990391 | DNA repair complex(GO:1990391) |
| 0.3 | 1.0 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
| 0.3 | 83.9 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.3 | 0.8 | GO:0097224 | sperm connecting piece(GO:0097224) |
| 0.3 | 1.8 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.3 | 7.1 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.3 | 1.0 | GO:0036338 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
| 0.2 | 3.0 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.2 | 1.5 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.2 | 4.1 | GO:0016342 | catenin complex(GO:0016342) |
| 0.2 | 59.5 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.2 | 119.1 | GO:0016607 | nuclear speck(GO:0016607) |
| 0.2 | 1.7 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
| 0.2 | 1.0 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
| 0.2 | 1.8 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.2 | 0.9 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 0.2 | 2.9 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 0.2 | 4.7 | GO:0000786 | nucleosome(GO:0000786) |
| 0.2 | 0.4 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 0.2 | 2.4 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.2 | 11.1 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.2 | 2.4 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.2 | 4.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.2 | 1.7 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.2 | 0.6 | GO:0005600 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
| 0.2 | 0.6 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
| 0.2 | 40.8 | GO:0000922 | spindle pole(GO:0000922) |
| 0.2 | 2.7 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.2 | 3.1 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
| 0.2 | 0.6 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
| 0.2 | 1.8 | GO:0000791 | euchromatin(GO:0000791) |
| 0.2 | 11.3 | GO:0031519 | PcG protein complex(GO:0031519) |
| 0.2 | 0.4 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.2 | 6.5 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
| 0.2 | 2.2 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.2 | 2.9 | GO:0042555 | MCM complex(GO:0042555) |
| 0.2 | 4.6 | GO:0043596 | nuclear replication fork(GO:0043596) |
| 0.2 | 3.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.2 | 1.5 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.2 | 3.6 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.2 | 52.9 | GO:0000790 | nuclear chromatin(GO:0000790) |
| 0.2 | 0.7 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.2 | 5.6 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
| 0.2 | 0.6 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
| 0.2 | 0.5 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
| 0.2 | 2.0 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.2 | 4.7 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.2 | 2.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.2 | 0.7 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.2 | 1.4 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 0.2 | 3.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.2 | 3.6 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.2 | 1.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.2 | 1.0 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.2 | 64.6 | GO:0031965 | nuclear membrane(GO:0031965) |
| 0.2 | 1.1 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.2 | 0.5 | GO:0002947 | tumor necrosis factor receptor superfamily complex(GO:0002947) |
| 0.2 | 0.3 | GO:0031417 | NatC complex(GO:0031417) |
| 0.2 | 15.6 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.1 | 1.2 | GO:0005811 | lipid particle(GO:0005811) |
| 0.1 | 14.0 | GO:0031902 | late endosome membrane(GO:0031902) |
| 0.1 | 1.1 | GO:0030684 | preribosome(GO:0030684) |
| 0.1 | 22.5 | GO:0005795 | Golgi stack(GO:0005795) |
| 0.1 | 22.8 | GO:0044452 | nucleolar part(GO:0044452) |
| 0.1 | 0.3 | GO:0045120 | pronucleus(GO:0045120) |
| 0.1 | 0.7 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.1 | 0.5 | GO:0036156 | inner dynein arm(GO:0036156) |
| 0.1 | 1.1 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.1 | 15.2 | GO:0030667 | secretory granule membrane(GO:0030667) |
| 0.1 | 0.7 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.1 | 11.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.1 | 4.6 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.1 | 3.7 | GO:0031904 | endosome lumen(GO:0031904) |
| 0.1 | 12.0 | GO:0005814 | centriole(GO:0005814) |
| 0.1 | 0.9 | GO:0032280 | symmetric synapse(GO:0032280) |
| 0.1 | 4.4 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.1 | 0.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.1 | 0.5 | GO:0045259 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) proton-transporting ATP synthase complex(GO:0045259) |
| 0.1 | 0.9 | GO:0031415 | NatA complex(GO:0031415) |
| 0.1 | 2.0 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.1 | 1.5 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
| 0.1 | 2.1 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.1 | 0.9 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.1 | 0.8 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.1 | 1.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.1 | 0.8 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.1 | 54.9 | GO:0005694 | chromosome(GO:0005694) |
| 0.1 | 0.4 | GO:0022626 | cytosolic ribosome(GO:0022626) |
| 0.1 | 24.7 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
| 0.1 | 0.3 | GO:0032153 | cell division site(GO:0032153) cell division site part(GO:0032155) |
| 0.1 | 0.3 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 0.1 | 15.5 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
| 0.1 | 1.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.1 | 0.3 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.1 | 0.3 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
| 0.1 | 1.9 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
| 0.1 | 0.9 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.1 | 0.7 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 0.1 | 1.0 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
| 0.1 | 0.3 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.1 | 0.7 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
| 0.1 | 0.8 | GO:0032437 | cuticular plate(GO:0032437) |
| 0.1 | 12.6 | GO:0034774 | secretory granule lumen(GO:0034774) |
| 0.1 | 1.0 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
| 0.1 | 0.4 | GO:0090576 | transcription factor TFIIIB complex(GO:0000126) RNA polymerase III transcription factor complex(GO:0090576) |
| 0.1 | 0.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.1 | 0.5 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.1 | 0.2 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 0.1 | 0.4 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.1 | 0.4 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
| 0.1 | 0.9 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.1 | 47.4 | GO:0005730 | nucleolus(GO:0005730) |
| 0.1 | 0.5 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
| 0.1 | 42.7 | GO:0000139 | Golgi membrane(GO:0000139) |
| 0.1 | 1.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.1 | 0.4 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
| 0.1 | 3.9 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.1 | 0.4 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.1 | 0.2 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
| 0.1 | 1.2 | GO:0005844 | polysome(GO:0005844) |
| 0.1 | 0.2 | GO:0032059 | bleb(GO:0032059) |
| 0.1 | 0.2 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
| 0.0 | 0.5 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.0 | 0.7 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
| 0.0 | 1.0 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.0 | 0.2 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.0 | 0.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.0 | 4.9 | GO:0005813 | centrosome(GO:0005813) |
| 0.0 | 0.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.0 | 0.6 | GO:0045335 | phagocytic vesicle(GO:0045335) |
| 0.0 | 0.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.0 | 1.0 | GO:0098791 | Golgi subcompartment(GO:0098791) |
| 0.0 | 5.2 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
| 0.0 | 0.4 | GO:0000145 | exocyst(GO:0000145) |
| 0.0 | 2.4 | GO:0001669 | acrosomal vesicle(GO:0001669) |
| 0.0 | 0.3 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.0 | 1.8 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.0 | 0.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.0 | 0.3 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.0 | 212.5 | GO:0016021 | integral component of membrane(GO:0016021) |
| 0.0 | 1.7 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.0 | 0.1 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.0 | 4.0 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.0 | 0.2 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.0 | 226.8 | GO:0005634 | nucleus(GO:0005634) |
| 0.0 | 0.2 | GO:0005865 | striated muscle thin filament(GO:0005865) |
| 0.0 | 66.3 | GO:0005829 | cytosol(GO:0005829) |
| 0.0 | 0.0 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 0.0 | 0.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
| 0.0 | 0.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.0 | 0.0 | GO:1990745 | EARP complex(GO:1990745) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.1 | 20.2 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 4.7 | 28.1 | GO:0004918 | interleukin-8 receptor activity(GO:0004918) |
| 4.6 | 13.9 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 4.0 | 12.0 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
| 3.9 | 11.8 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
| 3.6 | 14.2 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 3.5 | 3.5 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
| 3.5 | 24.4 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
| 3.0 | 15.2 | GO:0030109 | HLA-B specific inhibitory MHC class I receptor activity(GO:0030109) |
| 2.7 | 8.2 | GO:0042947 | glucoside transmembrane transporter activity(GO:0042947) |
| 2.7 | 29.7 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
| 2.7 | 13.4 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 2.6 | 7.9 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 2.6 | 18.1 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
| 2.6 | 12.8 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
| 2.5 | 7.5 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
| 2.5 | 7.4 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 2.5 | 7.4 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
| 2.4 | 7.2 | GO:0009032 | thymidine phosphorylase activity(GO:0009032) pyrimidine-nucleoside phosphorylase activity(GO:0016154) |
| 2.3 | 6.9 | GO:0004651 | polynucleotide 5'-phosphatase activity(GO:0004651) |
| 2.3 | 9.1 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 2.3 | 6.8 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 2.2 | 22.5 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 2.2 | 8.9 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 2.2 | 8.7 | GO:0033897 | ribonuclease T2 activity(GO:0033897) |
| 2.1 | 19.3 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
| 2.1 | 6.4 | GO:0001861 | complement component C4b receptor activity(GO:0001861) complement component C3b receptor activity(GO:0004877) |
| 2.1 | 6.4 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) tRNA guanylyltransferase activity(GO:0008193) |
| 2.1 | 8.3 | GO:0032427 | GBD domain binding(GO:0032427) |
| 2.0 | 12.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 1.9 | 5.8 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
| 1.9 | 3.9 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
| 1.9 | 5.8 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
| 1.9 | 23.2 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 1.9 | 13.4 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 1.9 | 5.7 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
| 1.9 | 30.2 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 1.9 | 7.5 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
| 1.8 | 10.8 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 1.8 | 16.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 1.8 | 5.3 | GO:0098973 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
| 1.7 | 1.7 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
| 1.7 | 10.3 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
| 1.7 | 24.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 1.7 | 6.8 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
| 1.7 | 30.2 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
| 1.7 | 8.4 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 1.6 | 14.6 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 1.6 | 3.2 | GO:0031755 | endothelial differentiation G-protein coupled receptor binding(GO:0031753) Edg-2 lysophosphatidic acid receptor binding(GO:0031755) |
| 1.6 | 6.4 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
| 1.6 | 4.8 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
| 1.6 | 26.8 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 1.6 | 6.3 | GO:0034736 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
| 1.6 | 10.9 | GO:0016936 | galactoside binding(GO:0016936) |
| 1.5 | 4.6 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
| 1.5 | 4.6 | GO:0048257 | 3'-flap endonuclease activity(GO:0048257) |
| 1.5 | 4.6 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 1.5 | 4.5 | GO:0047693 | GTP diphosphatase activity(GO:0036219) 2-hydroxy-adenosine triphosphate pyrophosphatase activity(GO:0044713) 2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity(GO:0044714) ATP diphosphatase activity(GO:0047693) |
| 1.5 | 14.8 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 1.5 | 5.9 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
| 1.5 | 13.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 1.4 | 4.3 | GO:0004615 | phosphomannomutase activity(GO:0004615) |
| 1.4 | 7.2 | GO:0098808 | mRNA cap binding(GO:0098808) |
| 1.4 | 27.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 1.4 | 2.8 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 1.4 | 5.6 | GO:0015207 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
| 1.4 | 18.2 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 1.4 | 1.4 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
| 1.4 | 9.7 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
| 1.4 | 9.6 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 1.4 | 5.4 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 1.3 | 6.7 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
| 1.3 | 6.7 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
| 1.3 | 9.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 1.3 | 2.6 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
| 1.3 | 5.3 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 1.3 | 3.9 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 1.3 | 3.9 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
| 1.3 | 3.8 | GO:0050405 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
| 1.3 | 6.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 1.3 | 3.8 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
| 1.3 | 5.0 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
| 1.2 | 5.0 | GO:0032089 | NACHT domain binding(GO:0032089) |
| 1.2 | 3.7 | GO:0033142 | progesterone receptor binding(GO:0033142) |
| 1.2 | 3.7 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
| 1.2 | 2.5 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
| 1.2 | 3.7 | GO:0005055 | laminin receptor activity(GO:0005055) |
| 1.2 | 13.5 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
| 1.2 | 6.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 1.2 | 11.0 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 1.2 | 15.8 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 1.2 | 3.5 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 1.2 | 4.7 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
| 1.2 | 2.4 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 1.2 | 7.0 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 1.2 | 12.8 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 1.2 | 3.5 | GO:0005174 | CD40 receptor binding(GO:0005174) |
| 1.2 | 10.4 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 1.1 | 11.5 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 1.1 | 9.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 1.1 | 3.4 | GO:0005369 | taurine transmembrane transporter activity(GO:0005368) taurine:sodium symporter activity(GO:0005369) |
| 1.1 | 23.6 | GO:0005522 | profilin binding(GO:0005522) |
| 1.1 | 7.8 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
| 1.1 | 7.8 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 1.1 | 8.7 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 1.1 | 4.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
| 1.1 | 5.4 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
| 1.1 | 18.0 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
| 1.1 | 4.2 | GO:0008311 | double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
| 1.1 | 7.4 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
| 1.0 | 5.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 1.0 | 3.1 | GO:0001133 | RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding(GO:0001133) |
| 1.0 | 7.1 | GO:0019862 | IgA binding(GO:0019862) |
| 1.0 | 5.0 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 1.0 | 3.0 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
| 1.0 | 4.0 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
| 1.0 | 19.0 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 1.0 | 4.0 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
| 1.0 | 4.0 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 1.0 | 13.9 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 1.0 | 3.0 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 1.0 | 2.0 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 1.0 | 8.9 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 1.0 | 4.9 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 1.0 | 7.8 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 1.0 | 5.8 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
| 1.0 | 17.1 | GO:0003796 | lysozyme activity(GO:0003796) |
| 1.0 | 1.9 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.9 | 4.7 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
| 0.9 | 2.8 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 0.9 | 2.8 | GO:0097001 | ceramide binding(GO:0097001) |
| 0.9 | 2.8 | GO:0017129 | triglyceride binding(GO:0017129) |
| 0.9 | 3.6 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.9 | 10.0 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 0.9 | 26.2 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.9 | 11.8 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.9 | 3.6 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
| 0.9 | 10.8 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.9 | 4.5 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.9 | 2.7 | GO:0005135 | erythropoietin receptor binding(GO:0005128) interleukin-3 receptor binding(GO:0005135) |
| 0.9 | 3.6 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 0.9 | 7.2 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
| 0.9 | 2.7 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 0.9 | 2.7 | GO:0016436 | rRNA (uridine-2'-O-)-methyltransferase activity(GO:0008650) rRNA (uridine) methyltransferase activity(GO:0016436) |
| 0.9 | 8.0 | GO:0030884 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
| 0.9 | 8.9 | GO:0015925 | galactosidase activity(GO:0015925) |
| 0.9 | 21.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.9 | 58.3 | GO:0019843 | rRNA binding(GO:0019843) |
| 0.9 | 3.5 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 0.9 | 8.8 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 0.9 | 6.2 | GO:0015254 | glycerol channel activity(GO:0015254) |
| 0.9 | 2.6 | GO:0016263 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity(GO:0016263) |
| 0.9 | 5.2 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
| 0.9 | 2.6 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
| 0.9 | 14.5 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.9 | 8.5 | GO:0019863 | IgE binding(GO:0019863) |
| 0.9 | 36.6 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.9 | 2.6 | GO:0030617 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) |
| 0.8 | 3.4 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 0.8 | 7.6 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.8 | 5.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.8 | 0.8 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
| 0.8 | 2.5 | GO:0036479 | GTP-dependent protein kinase activity(GO:0034211) peroxidase inhibitor activity(GO:0036479) |
| 0.8 | 3.4 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
| 0.8 | 5.8 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.8 | 2.5 | GO:0031691 | alpha-1A adrenergic receptor binding(GO:0031691) follicle-stimulating hormone receptor binding(GO:0031762) |
| 0.8 | 4.1 | GO:0035500 | MH2 domain binding(GO:0035500) |
| 0.8 | 6.5 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 0.8 | 3.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 0.8 | 12.0 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.8 | 1.6 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
| 0.8 | 5.6 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
| 0.8 | 2.4 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
| 0.8 | 4.7 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.8 | 16.5 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
| 0.8 | 3.1 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
| 0.8 | 3.9 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.8 | 7.8 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
| 0.8 | 3.1 | GO:0030620 | U2 snRNA binding(GO:0030620) |
| 0.8 | 6.2 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 0.8 | 7.7 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.8 | 14.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.8 | 1.5 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 0.8 | 2.3 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
| 0.8 | 3.8 | GO:0004914 | interleukin-3 receptor activity(GO:0004912) interleukin-5 receptor activity(GO:0004914) |
| 0.8 | 5.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.8 | 2.3 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
| 0.8 | 3.0 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
| 0.7 | 3.0 | GO:0045569 | TRAIL binding(GO:0045569) |
| 0.7 | 8.2 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
| 0.7 | 3.0 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
| 0.7 | 10.4 | GO:0051434 | BH3 domain binding(GO:0051434) |
| 0.7 | 4.5 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.7 | 55.5 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.7 | 14.5 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.7 | 2.2 | GO:0008841 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
| 0.7 | 2.1 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
| 0.7 | 5.0 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 0.7 | 4.3 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
| 0.7 | 2.1 | GO:0019777 | Atg12 transferase activity(GO:0019777) |
| 0.7 | 1.4 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.7 | 26.0 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.7 | 14.0 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.7 | 5.6 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.7 | 5.5 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 0.7 | 2.1 | GO:0019808 | polyamine binding(GO:0019808) |
| 0.7 | 5.5 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 0.7 | 2.1 | GO:0000224 | peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity(GO:0000224) |
| 0.7 | 2.7 | GO:0004146 | dihydrofolate reductase activity(GO:0004146) |
| 0.7 | 20.9 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.7 | 2.0 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
| 0.7 | 10.0 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.7 | 3.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.7 | 8.5 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.7 | 7.9 | GO:0035197 | siRNA binding(GO:0035197) |
| 0.7 | 7.9 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.7 | 32.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.6 | 1.9 | GO:0019779 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
| 0.6 | 18.2 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 0.6 | 3.9 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
| 0.6 | 2.6 | GO:0061656 | SUMO conjugating enzyme activity(GO:0061656) |
| 0.6 | 1.3 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 0.6 | 14.2 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
| 0.6 | 1.9 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
| 0.6 | 3.9 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) |
| 0.6 | 7.7 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
| 0.6 | 13.8 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
| 0.6 | 5.0 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
| 0.6 | 1.3 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.6 | 20.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.6 | 7.4 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.6 | 8.6 | GO:0019864 | IgG binding(GO:0019864) |
| 0.6 | 4.9 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 0.6 | 5.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.6 | 3.7 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.6 | 1.8 | GO:0016005 | phospholipase A2 activator activity(GO:0016005) |
| 0.6 | 2.4 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.6 | 5.5 | GO:1990405 | protein antigen binding(GO:1990405) |
| 0.6 | 3.6 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.6 | 1.8 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 0.6 | 2.4 | GO:0046625 | sphingolipid binding(GO:0046625) |
| 0.6 | 1.8 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.6 | 1.8 | GO:0004407 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
| 0.6 | 12.5 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.6 | 3.6 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.6 | 11.9 | GO:0015923 | mannosidase activity(GO:0015923) |
| 0.6 | 1.8 | GO:0015432 | bile acid-exporting ATPase activity(GO:0015432) |
| 0.6 | 5.9 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
| 0.6 | 13.0 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.6 | 4.7 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.6 | 2.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.6 | 4.1 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
| 0.6 | 5.2 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
| 0.6 | 0.6 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
| 0.6 | 3.4 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
| 0.6 | 51.9 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.6 | 2.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.6 | 1.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
| 0.6 | 19.1 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 0.6 | 1.7 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 0.6 | 2.8 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.6 | 26.1 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
| 0.6 | 27.7 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.6 | 2.2 | GO:0043273 | CTPase activity(GO:0043273) |
| 0.6 | 1.7 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.6 | 11.6 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
| 0.6 | 5.5 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.6 | 5.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.5 | 5.5 | GO:0016004 | phospholipase activator activity(GO:0016004) |
| 0.5 | 4.4 | GO:0034594 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity(GO:0034485) phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
| 0.5 | 1.6 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
| 0.5 | 4.3 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.5 | 3.8 | GO:0019826 | oxygen sensor activity(GO:0019826) |
| 0.5 | 15.1 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.5 | 108.3 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.5 | 2.1 | GO:0032408 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
| 0.5 | 9.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.5 | 16.5 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.5 | 4.2 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 0.5 | 2.1 | GO:0002046 | opsin binding(GO:0002046) |
| 0.5 | 4.2 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 0.5 | 12.5 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 0.5 | 2.6 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
| 0.5 | 19.1 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.5 | 1.5 | GO:0090541 | MIT domain binding(GO:0090541) |
| 0.5 | 6.2 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 0.5 | 7.7 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.5 | 2.0 | GO:0048040 | UDP-glucuronate decarboxylase activity(GO:0048040) |
| 0.5 | 16.4 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.5 | 3.0 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
| 0.5 | 1.5 | GO:0001851 | complement component C3b binding(GO:0001851) |
| 0.5 | 1.0 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 0.5 | 1.5 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
| 0.5 | 21.0 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
| 0.5 | 0.5 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.5 | 4.4 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
| 0.5 | 1.5 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
| 0.5 | 2.0 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
| 0.5 | 1.5 | GO:0004056 | argininosuccinate lyase activity(GO:0004056) |
| 0.5 | 2.4 | GO:0019003 | GDP binding(GO:0019003) |
| 0.5 | 1.5 | GO:0043739 | G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739) |
| 0.5 | 22.8 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.5 | 96.9 | GO:0003823 | antigen binding(GO:0003823) |
| 0.5 | 2.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.5 | 12.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.5 | 2.4 | GO:0004803 | transposase activity(GO:0004803) |
| 0.5 | 1.4 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
| 0.5 | 2.4 | GO:0034061 | DNA polymerase activity(GO:0034061) |
| 0.5 | 5.6 | GO:0015926 | glucosidase activity(GO:0015926) |
| 0.5 | 1.4 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
| 0.5 | 3.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.5 | 5.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
| 0.5 | 1.8 | GO:0016882 | phosphoribosylamine-glycine ligase activity(GO:0004637) phosphoribosylformylglycinamidine cyclo-ligase activity(GO:0004641) phosphoribosylglycinamide formyltransferase activity(GO:0004644) cyclo-ligase activity(GO:0016882) |
| 0.5 | 3.2 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
| 0.5 | 11.0 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.5 | 11.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.5 | 0.5 | GO:0008312 | 7S RNA binding(GO:0008312) |
| 0.5 | 12.7 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 0.5 | 0.9 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.5 | 1.8 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.5 | 5.9 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
| 0.5 | 19.8 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.4 | 8.9 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
| 0.4 | 0.4 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.4 | 7.5 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
| 0.4 | 2.6 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
| 0.4 | 23.6 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.4 | 3.1 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
| 0.4 | 3.1 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 0.4 | 1.7 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
| 0.4 | 5.2 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
| 0.4 | 3.5 | GO:0043426 | MRF binding(GO:0043426) |
| 0.4 | 4.3 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 0.4 | 1.7 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
| 0.4 | 8.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.4 | 3.4 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
| 0.4 | 4.3 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
| 0.4 | 1.7 | GO:0038181 | bile acid receptor activity(GO:0038181) |
| 0.4 | 3.0 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.4 | 1.3 | GO:0008893 | guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity(GO:0008893) diphosphoric monoester hydrolase activity(GO:0016794) |
| 0.4 | 1.7 | GO:0070012 | oligopeptidase activity(GO:0070012) |
| 0.4 | 6.7 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.4 | 7.9 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.4 | 2.1 | GO:0048030 | disaccharide binding(GO:0048030) |
| 0.4 | 5.4 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.4 | 30.5 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.4 | 1.2 | GO:0090409 | malonyl-CoA synthetase activity(GO:0090409) |
| 0.4 | 1.2 | GO:0070039 | rRNA (guanosine-2'-O-)-methyltransferase activity(GO:0070039) |
| 0.4 | 1.6 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
| 0.4 | 1.2 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
| 0.4 | 1.6 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.4 | 1.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.4 | 9.6 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.4 | 10.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.4 | 5.9 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.4 | 0.8 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
| 0.4 | 1.2 | GO:0016608 | growth hormone-releasing hormone activity(GO:0016608) |
| 0.4 | 1.9 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 0.4 | 0.8 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
| 0.4 | 3.4 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.4 | 14.0 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.4 | 2.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.4 | 20.7 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.4 | 0.8 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 0.4 | 1.1 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
| 0.4 | 1.9 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.4 | 3.7 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
| 0.4 | 4.8 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.4 | 3.3 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 0.4 | 2.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.4 | 2.6 | GO:0089720 | caspase binding(GO:0089720) |
| 0.4 | 9.2 | GO:0043495 | protein anchor(GO:0043495) |
| 0.4 | 2.6 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.4 | 12.9 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.4 | 2.9 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.4 | 6.2 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.4 | 7.7 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.4 | 6.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.4 | 15.5 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.4 | 6.8 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
| 0.4 | 7.2 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.4 | 2.5 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.4 | 1.8 | GO:0042806 | fucose binding(GO:0042806) |
| 0.4 | 27.0 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.4 | 1.8 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
| 0.4 | 17.9 | GO:0004532 | exoribonuclease activity(GO:0004532) |
| 0.3 | 2.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.3 | 3.5 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
| 0.3 | 1.0 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
| 0.3 | 6.6 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.3 | 2.1 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
| 0.3 | 11.4 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.3 | 1.0 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.3 | 4.1 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.3 | 1.4 | GO:0055100 | adiponectin binding(GO:0055100) |
| 0.3 | 4.1 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
| 0.3 | 1.4 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 0.3 | 3.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.3 | 0.7 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.3 | 4.4 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.3 | 2.0 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.3 | 1.0 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) aspartate-tRNA(Asn) ligase activity(GO:0050560) |
| 0.3 | 1.7 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 0.3 | 1.0 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
| 0.3 | 1.3 | GO:0016672 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) |
| 0.3 | 1.3 | GO:0008424 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
| 0.3 | 8.5 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
| 0.3 | 6.5 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
| 0.3 | 14.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.3 | 3.6 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.3 | 1.0 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
| 0.3 | 2.2 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.3 | 1.6 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
| 0.3 | 1.3 | GO:0016849 | phosphorus-oxygen lyase activity(GO:0016849) |
| 0.3 | 1.3 | GO:0004420 | hydroxymethylglutaryl-CoA reductase (NADPH) activity(GO:0004420) hydroxymethylglutaryl-CoA reductase activity(GO:0042282) |
| 0.3 | 1.6 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.3 | 26.7 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.3 | 1.0 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
| 0.3 | 11.1 | GO:0022829 | wide pore channel activity(GO:0022829) |
| 0.3 | 27.9 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.3 | 10.3 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.3 | 5.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.3 | 25.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.3 | 0.6 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 0.3 | 1.5 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 0.3 | 1.5 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.3 | 2.4 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.3 | 3.0 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.3 | 0.9 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
| 0.3 | 8.2 | GO:0048365 | Rac GTPase binding(GO:0048365) |
| 0.3 | 1.2 | GO:0001132 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
| 0.3 | 1.2 | GO:0031208 | POZ domain binding(GO:0031208) |
| 0.3 | 4.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.3 | 5.9 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.3 | 2.0 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
| 0.3 | 3.2 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
| 0.3 | 1.2 | GO:0004492 | methylmalonyl-CoA decarboxylase activity(GO:0004492) |
| 0.3 | 3.7 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.3 | 2.3 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 0.3 | 0.9 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
| 0.3 | 16.9 | GO:0034062 | RNA polymerase activity(GO:0034062) |
| 0.3 | 3.1 | GO:0016893 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016893) |
| 0.3 | 2.6 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 0.3 | 11.7 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.3 | 7.4 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.3 | 1.4 | GO:1990460 | leptin receptor binding(GO:1990460) |
| 0.3 | 1.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
| 0.3 | 1.7 | GO:0042834 | peptidoglycan binding(GO:0042834) |
| 0.3 | 7.2 | GO:0004518 | nuclease activity(GO:0004518) |
| 0.3 | 0.8 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.3 | 0.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 0.3 | 0.8 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
| 0.3 | 1.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 0.3 | 21.7 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
| 0.3 | 3.3 | GO:0070699 | type II activin receptor binding(GO:0070699) |
| 0.3 | 1.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
| 0.3 | 2.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 0.3 | 2.4 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.3 | 1.1 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 0.3 | 2.1 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 0.3 | 1.1 | GO:0008832 | dGTPase activity(GO:0008832) triphosphoric monoester hydrolase activity(GO:0016793) guanyl deoxyribonucleotide binding(GO:0032560) dGTP binding(GO:0032567) |
| 0.3 | 6.1 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.3 | 0.3 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
| 0.3 | 0.8 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.3 | 0.5 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
| 0.3 | 52.8 | GO:0004386 | helicase activity(GO:0004386) |
| 0.3 | 0.5 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 0.3 | 1.0 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
| 0.3 | 4.2 | GO:0070411 | I-SMAD binding(GO:0070411) |
| 0.3 | 0.8 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
| 0.3 | 2.9 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.3 | 3.9 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.3 | 4.9 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.3 | 3.6 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.3 | 2.0 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.3 | 1.8 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 0.3 | 1.0 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
| 0.3 | 10.2 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.3 | 1.5 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.3 | 1.8 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.3 | 8.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.2 | 1.0 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 0.2 | 2.0 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.2 | 8.7 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.2 | 0.7 | GO:0004577 | N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity(GO:0004577) |
| 0.2 | 16.0 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
| 0.2 | 8.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.2 | 0.7 | GO:0005139 | interleukin-7 receptor binding(GO:0005139) |
| 0.2 | 5.6 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
| 0.2 | 8.0 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.2 | 1.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.2 | 2.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.2 | 1.7 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.2 | 1.0 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
| 0.2 | 1.9 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.2 | 0.7 | GO:0004875 | complement receptor activity(GO:0004875) |
| 0.2 | 2.3 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.2 | 1.2 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 0.2 | 0.5 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
| 0.2 | 6.3 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.2 | 6.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.2 | 3.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.2 | 0.7 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
| 0.2 | 2.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.2 | 8.8 | GO:0019905 | syntaxin binding(GO:0019905) |
| 0.2 | 14.5 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
| 0.2 | 0.9 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
| 0.2 | 1.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.2 | 0.7 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.2 | 1.1 | GO:0004798 | thymidylate kinase activity(GO:0004798) |
| 0.2 | 1.1 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
| 0.2 | 2.9 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 0.2 | 1.1 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 0.2 | 0.4 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
| 0.2 | 9.4 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.2 | 0.9 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
| 0.2 | 1.6 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.2 | 1.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.2 | 25.3 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
| 0.2 | 1.1 | GO:0052743 | inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) inositol tetrakisphosphate phosphatase activity(GO:0052743) |
| 0.2 | 2.4 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
| 0.2 | 1.7 | GO:0046790 | virion binding(GO:0046790) |
| 0.2 | 1.9 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.2 | 4.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.2 | 2.3 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
| 0.2 | 2.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.2 | 18.7 | GO:0005525 | GTP binding(GO:0005525) |
| 0.2 | 105.4 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.2 | 0.8 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
| 0.2 | 1.7 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.2 | 9.0 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.2 | 4.3 | GO:0019211 | phosphatase activator activity(GO:0019211) |
| 0.2 | 2.1 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
| 0.2 | 12.3 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
| 0.2 | 1.4 | GO:0097108 | smoothened binding(GO:0005119) hedgehog family protein binding(GO:0097108) |
| 0.2 | 0.6 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
| 0.2 | 1.4 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.2 | 4.1 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
| 0.2 | 1.2 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
| 0.2 | 2.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
| 0.2 | 3.2 | GO:0032183 | SUMO binding(GO:0032183) |
| 0.2 | 2.2 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
| 0.2 | 1.4 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.2 | 1.0 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.2 | 1.0 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
| 0.2 | 1.4 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.2 | 0.6 | GO:0035730 | S-nitrosoglutathione binding(GO:0035730) dinitrosyl-iron complex binding(GO:0035731) |
| 0.2 | 1.8 | GO:0070728 | leucine binding(GO:0070728) |
| 0.2 | 1.8 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.2 | 0.8 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
| 0.2 | 1.8 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
| 0.2 | 6.4 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
| 0.2 | 7.4 | GO:0004540 | ribonuclease activity(GO:0004540) |
| 0.2 | 2.1 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.2 | 0.8 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
| 0.2 | 0.4 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
| 0.2 | 1.9 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 0.2 | 1.5 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.2 | 3.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.2 | 0.6 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.2 | 1.3 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.2 | 1.9 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.2 | 20.8 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
| 0.2 | 7.8 | GO:0003684 | damaged DNA binding(GO:0003684) |
| 0.2 | 0.6 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
| 0.2 | 1.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 0.2 | 2.2 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
| 0.2 | 3.7 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.2 | 3.8 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 0.2 | 5.8 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.2 | 0.7 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
| 0.2 | 1.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.2 | 2.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
| 0.2 | 1.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.2 | 4.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.2 | 3.5 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.2 | 2.1 | GO:0048156 | tau protein binding(GO:0048156) |
| 0.2 | 0.2 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
| 0.2 | 4.5 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.2 | 0.3 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
| 0.2 | 2.1 | GO:0010857 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) calcium-dependent protein kinase activity(GO:0010857) |
| 0.2 | 0.7 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
| 0.2 | 1.6 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
| 0.2 | 0.5 | GO:0047315 | kynurenine-glyoxylate transaminase activity(GO:0047315) |
| 0.2 | 0.7 | GO:0051500 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
| 0.2 | 8.8 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.2 | 3.5 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.2 | 2.5 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
| 0.2 | 6.8 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.2 | 0.8 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.2 | 2.3 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
| 0.2 | 6.4 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
| 0.2 | 0.8 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 0.2 | 0.5 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 0.2 | 6.5 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.2 | 1.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 0.2 | 4.7 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.2 | 4.1 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
| 0.2 | 0.6 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.2 | 3.0 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
| 0.2 | 1.4 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
| 0.2 | 2.7 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.2 | 30.7 | GO:0001047 | core promoter binding(GO:0001047) |
| 0.2 | 5.5 | GO:0042393 | histone binding(GO:0042393) |
| 0.2 | 0.9 | GO:0003909 | DNA ligase activity(GO:0003909) |
| 0.2 | 1.4 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.2 | 3.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
| 0.2 | 6.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.2 | 19.1 | GO:0043130 | ubiquitin binding(GO:0043130) |
| 0.2 | 1.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
| 0.2 | 1.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.2 | 0.9 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.2 | 0.5 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
| 0.1 | 6.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.1 | 0.3 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
| 0.1 | 9.4 | GO:0035064 | methylated histone binding(GO:0035064) |
| 0.1 | 1.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
| 0.1 | 0.7 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 0.1 | 3.3 | GO:0046961 | hydrogen-exporting ATPase activity(GO:0036442) ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.1 | 404.5 | GO:0003677 | DNA binding(GO:0003677) |
| 0.1 | 0.8 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.1 | 50.1 | GO:0030246 | carbohydrate binding(GO:0030246) |
| 0.1 | 0.4 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
| 0.1 | 0.7 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.1 | 30.5 | GO:0005125 | cytokine activity(GO:0005125) |
| 0.1 | 0.4 | GO:0036328 | VEGF-C-activated receptor activity(GO:0036328) |
| 0.1 | 11.7 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.1 | 1.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.1 | 1.2 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.1 | 2.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.1 | 0.4 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
| 0.1 | 0.5 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 0.1 | 44.7 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.1 | 7.9 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
| 0.1 | 0.7 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 0.1 | 11.8 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.1 | 2.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.1 | 0.5 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
| 0.1 | 0.7 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.1 | 2.3 | GO:0008199 | ferric iron binding(GO:0008199) |
| 0.1 | 0.9 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 0.1 | 0.7 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
| 0.1 | 9.6 | GO:0003700 | transcription factor activity, sequence-specific DNA binding(GO:0003700) |
| 0.1 | 2.5 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.1 | 0.8 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
| 0.1 | 16.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.1 | 0.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
| 0.1 | 0.7 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.1 | 0.3 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.1 | 2.3 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
| 0.1 | 0.3 | GO:0042007 | interleukin-18 binding(GO:0042007) |
| 0.1 | 0.5 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
| 0.1 | 0.2 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.1 | 1.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.1 | 0.4 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
| 0.1 | 0.6 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.1 | 0.2 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
| 0.1 | 5.1 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
| 0.1 | 0.5 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 0.1 | 0.2 | GO:0019781 | NEDD8 activating enzyme activity(GO:0019781) |
| 0.1 | 0.3 | GO:0090422 | thiamine pyrophosphate transporter activity(GO:0090422) |
| 0.1 | 0.2 | GO:0008988 | rRNA (adenine-N6-)-methyltransferase activity(GO:0008988) |
| 0.1 | 0.3 | GO:0033842 | N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity(GO:0033842) |
| 0.1 | 1.5 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.1 | 0.3 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
| 0.1 | 1.9 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.1 | 0.2 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.1 | 3.6 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.1 | 1.4 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.1 | 0.8 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 0.1 | 0.3 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
| 0.1 | 0.3 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
| 0.1 | 0.5 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 0.1 | 0.5 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.1 | 1.0 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
| 0.1 | 2.8 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.1 | 46.0 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
| 0.1 | 12.1 | GO:0005178 | integrin binding(GO:0005178) |
| 0.1 | 0.2 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
| 0.1 | 2.9 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.1 | 0.1 | GO:0005110 | frizzled-2 binding(GO:0005110) |
| 0.1 | 1.8 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.1 | 0.2 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
| 0.1 | 1.9 | GO:0005521 | lamin binding(GO:0005521) |
| 0.1 | 0.5 | GO:0030298 | receptor signaling protein tyrosine kinase activator activity(GO:0030298) |
| 0.1 | 0.2 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.1 | 0.8 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
| 0.1 | 2.8 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
| 0.1 | 0.2 | GO:0070404 | NADH binding(GO:0070404) |
| 0.1 | 7.4 | GO:0008565 | protein transporter activity(GO:0008565) |
| 0.1 | 7.6 | GO:0003713 | transcription coactivator activity(GO:0003713) |
| 0.1 | 1.2 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
| 0.1 | 0.2 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
| 0.1 | 0.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.1 | 0.3 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.1 | 4.0 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
| 0.1 | 0.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.1 | 0.8 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.1 | 0.3 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.1 | 1.6 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.1 | 4.8 | GO:1901981 | phosphatidylinositol phosphate binding(GO:1901981) |
| 0.1 | 0.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.1 | 0.4 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 0.1 | 0.6 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.1 | 0.3 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 0.1 | 0.5 | GO:0043515 | kinetochore binding(GO:0043515) |
| 0.1 | 0.3 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
| 0.1 | 0.4 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.1 | 1.0 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.1 | 0.2 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
| 0.1 | 0.8 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.1 | 0.4 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
| 0.1 | 2.8 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.1 | 0.3 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
| 0.1 | 2.5 | GO:0031072 | heat shock protein binding(GO:0031072) |
| 0.1 | 1.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.1 | 0.5 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.1 | 1.5 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
| 0.1 | 1.1 | GO:0030515 | snoRNA binding(GO:0030515) |
| 0.1 | 0.4 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 0.1 | 0.3 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.1 | 0.4 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
| 0.1 | 0.5 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.1 | 0.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.1 | 0.7 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.1 | 0.2 | GO:0035276 | ethanol binding(GO:0035276) |
| 0.1 | 1.2 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
| 0.1 | 0.3 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
| 0.1 | 0.1 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.1 | 0.5 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.1 | 0.8 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
| 0.1 | 0.2 | GO:0004568 | chitinase activity(GO:0004568) |
| 0.1 | 0.4 | GO:0042301 | phosphate ion binding(GO:0042301) |
| 0.0 | 0.3 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
| 0.0 | 0.2 | GO:0004513 | neolactotetraosylceramide alpha-2,3-sialyltransferase activity(GO:0004513) lactosylceramide alpha-2,3-sialyltransferase activity(GO:0047291) |
| 0.0 | 0.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.0 | 0.1 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.0 | 1.0 | GO:0042171 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
| 0.0 | 0.1 | GO:0097689 | iron channel activity(GO:0097689) |
| 0.0 | 4.9 | GO:0003712 | transcription cofactor activity(GO:0003712) |
| 0.0 | 60.3 | GO:0003676 | nucleic acid binding(GO:0003676) |
| 0.0 | 0.9 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.0 | 0.2 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
| 0.0 | 1.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.0 | 0.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 0.0 | 0.4 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
| 0.0 | 0.2 | GO:0052901 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
| 0.0 | 0.1 | GO:0045182 | translation regulator activity(GO:0045182) |
| 0.0 | 0.4 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
| 0.0 | 0.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
| 0.0 | 0.0 | GO:1901375 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
| 0.0 | 0.2 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
| 0.0 | 0.2 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 0.0 | 2.4 | GO:0003682 | chromatin binding(GO:0003682) |
| 0.0 | 0.0 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
| 0.0 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.0 | 0.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
| 0.0 | 0.4 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.0 | 0.9 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.0 | 0.7 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.0 | 0.3 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.0 | 0.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.0 | 0.2 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
| 0.0 | 0.5 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.0 | 0.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.0 | 0.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 0.0 | 0.2 | GO:0051861 | glycolipid binding(GO:0051861) |
| 0.0 | 0.3 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.0 | 0.3 | GO:0002039 | p53 binding(GO:0002039) |
| 0.0 | 1.1 | GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
| 0.0 | 0.6 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.0 | 0.1 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.0 | 0.1 | GO:0008513 | secondary active organic cation transmembrane transporter activity(GO:0008513) |
| 0.0 | 0.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 0.0 | 0.2 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.0 | 2.6 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) |
| 0.0 | 0.0 | GO:0046715 | borate transmembrane transporter activity(GO:0046715) |
| 0.0 | 0.0 | GO:0005113 | patched binding(GO:0005113) |
| 0.0 | 0.1 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
| 0.0 | 0.1 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
| 0.0 | 0.4 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.4 | 5.4 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 2.1 | 2.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 1.7 | 201.2 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 1.4 | 50.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 1.3 | 16.7 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 1.3 | 21.8 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 1.2 | 78.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 1.2 | 80.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 1.2 | 45.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 1.1 | 2.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 1.1 | 7.6 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.9 | 41.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.9 | 37.0 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.8 | 27.8 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.8 | 40.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.7 | 55.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.7 | 19.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.7 | 29.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.7 | 72.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.7 | 51.7 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.6 | 18.5 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.6 | 14.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.6 | 42.1 | PID ATM PATHWAY | ATM pathway |
| 0.6 | 41.9 | PID IL4 2PATHWAY | IL4-mediated signaling events |
| 0.6 | 11.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.6 | 16.9 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
| 0.6 | 19.4 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.5 | 19.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 0.5 | 66.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.5 | 10.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.5 | 17.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.4 | 5.7 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
| 0.4 | 19.6 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 0.4 | 12.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.4 | 24.6 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.4 | 7.5 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.4 | 10.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.4 | 15.4 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.4 | 4.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.4 | 4.6 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
| 0.4 | 36.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.4 | 5.6 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.3 | 0.7 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.3 | 3.0 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 0.3 | 34.5 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.3 | 1.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.3 | 12.2 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.3 | 6.8 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.3 | 18.6 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.3 | 8.0 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.3 | 1.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.3 | 4.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.3 | 17.4 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.3 | 2.8 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.3 | 9.5 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.3 | 30.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.3 | 1.3 | PID EPO PATHWAY | EPO signaling pathway |
| 0.3 | 7.4 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.3 | 14.9 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.3 | 9.9 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.2 | 9.1 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.2 | 5.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.2 | 4.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.2 | 10.2 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 0.2 | 11.8 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.2 | 2.7 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 0.2 | 11.2 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.2 | 5.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.2 | 3.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.2 | 6.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.2 | 1.0 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.2 | 4.9 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.2 | 3.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.2 | 1.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 0.2 | 13.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.2 | 11.3 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.2 | 12.4 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.2 | 6.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.2 | 6.9 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.2 | 8.9 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.2 | 14.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.2 | 2.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.1 | 6.7 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.1 | 3.2 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
| 0.1 | 6.1 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.1 | 4.3 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.1 | 8.6 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.1 | 21.5 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.1 | 4.3 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.1 | 1.7 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
| 0.1 | 2.8 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.1 | 1.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.1 | 2.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.1 | 6.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.1 | 7.8 | PID CMYB PATHWAY | C-MYB transcription factor network |
| 0.1 | 1.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.1 | 2.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.1 | 3.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.1 | 9.0 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.1 | 7.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.1 | 1.7 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.1 | 2.0 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.1 | 3.2 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
| 0.1 | 3.1 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.1 | 2.9 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 0.1 | 1.7 | PID ATR PATHWAY | ATR signaling pathway |
| 0.1 | 0.9 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.1 | 0.4 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.1 | 4.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.1 | 0.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.1 | 2.4 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.1 | 1.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
| 0.1 | 0.9 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.0 | 2.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.0 | 18.6 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.0 | 0.9 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.0 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.0 | 0.6 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.0 | 1.1 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.0 | 5.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.0 | 0.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.0 | 0.1 | ST GAQ PATHWAY | G alpha q Pathway |
| 0.0 | 0.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.4 | 27.2 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
| 3.1 | 68.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 2.1 | 34.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 1.8 | 3.6 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
| 1.7 | 12.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
| 1.7 | 5.0 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 1.6 | 130.0 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 1.5 | 30.4 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 1.5 | 47.6 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 1.4 | 150.5 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 1.4 | 34.9 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 1.3 | 12.1 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
| 1.3 | 10.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 1.3 | 6.3 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 1.2 | 8.5 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
| 1.2 | 18.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 1.2 | 11.9 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 1.2 | 10.7 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 1.2 | 3.6 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
| 1.2 | 16.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 1.1 | 133.0 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 1.1 | 18.3 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
| 1.1 | 6.8 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 1.1 | 79.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 1.0 | 4.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 1.0 | 27.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 1.0 | 108.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 1.0 | 67.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 1.0 | 9.0 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
| 0.9 | 16.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.9 | 24.2 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.9 | 28.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.9 | 14.5 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
| 0.9 | 47.5 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
| 0.9 | 8.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.8 | 0.8 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.8 | 11.5 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.8 | 12.9 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.8 | 22.6 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.8 | 4.0 | REACTOME TRIF MEDIATED TLR3 SIGNALING | Genes involved in TRIF mediated TLR3 signaling |
| 0.8 | 20.6 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.8 | 8.7 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.8 | 19.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.8 | 7.8 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.8 | 3.0 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.7 | 13.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.7 | 39.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.7 | 12.7 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 0.6 | 27.7 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
| 0.6 | 22.4 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.6 | 15.8 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 0.6 | 10.7 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.6 | 15.3 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 0.6 | 10.8 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.6 | 13.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.6 | 11.0 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 0.6 | 20.8 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
| 0.6 | 21.3 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.6 | 13.5 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.6 | 1.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.6 | 28.5 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
| 0.6 | 15.6 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.5 | 9.2 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 0.5 | 10.2 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 0.5 | 5.7 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.5 | 13.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.5 | 3.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.5 | 28.3 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.5 | 81.8 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 0.5 | 7.9 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.5 | 10.3 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.5 | 18.6 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
| 0.5 | 2.4 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
| 0.5 | 1.4 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
| 0.4 | 48.2 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
| 0.4 | 6.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.4 | 4.8 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.4 | 1.3 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
| 0.4 | 28.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.4 | 5.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.4 | 11.8 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.4 | 13.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.4 | 22.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.4 | 11.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.4 | 4.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.4 | 10.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.4 | 19.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.4 | 10.7 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
| 0.4 | 11.6 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 0.4 | 9.2 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.4 | 7.3 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
| 0.4 | 1.5 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
| 0.4 | 19.9 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.4 | 103.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.4 | 13.1 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.4 | 4.0 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.3 | 5.9 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.3 | 19.6 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.3 | 12.3 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.3 | 12.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.3 | 9.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.3 | 2.8 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.3 | 3.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.3 | 6.7 | REACTOME TRANSLATION | Genes involved in Translation |
| 0.3 | 4.9 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
| 0.3 | 10.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.3 | 17.2 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
| 0.3 | 15.6 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.3 | 24.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.3 | 1.5 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.3 | 7.4 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
| 0.3 | 6.1 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.3 | 2.9 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
| 0.3 | 23.9 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
| 0.3 | 3.7 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.3 | 1.7 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
| 0.3 | 6.5 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.3 | 10.7 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.3 | 4.3 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.3 | 7.2 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.3 | 1.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.3 | 9.0 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
| 0.3 | 2.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.2 | 137.3 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
| 0.2 | 10.8 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
| 0.2 | 5.1 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.2 | 6.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.2 | 8.4 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 0.2 | 2.6 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
| 0.2 | 1.7 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
| 0.2 | 5.4 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.2 | 4.5 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.2 | 2.2 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
| 0.2 | 6.5 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
| 0.2 | 5.7 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.2 | 1.1 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.2 | 5.1 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
| 0.2 | 6.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.2 | 4.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.2 | 5.5 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
| 0.2 | 8.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.2 | 0.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 0.2 | 4.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.2 | 3.1 | REACTOME HIV LIFE CYCLE | Genes involved in HIV Life Cycle |
| 0.2 | 3.2 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
| 0.2 | 8.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.2 | 3.1 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.2 | 0.3 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
| 0.2 | 3.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.2 | 3.7 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
| 0.1 | 3.5 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.1 | 7.9 | REACTOME MEIOSIS | Genes involved in Meiosis |
| 0.1 | 3.3 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.1 | 2.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
| 0.1 | 4.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.1 | 8.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.1 | 1.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.1 | 21.1 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.1 | 5.9 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.1 | 0.7 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
| 0.1 | 9.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.1 | 2.0 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.1 | 2.5 | REACTOME GABA B RECEPTOR ACTIVATION | Genes involved in GABA B receptor activation |
| 0.1 | 2.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.1 | 2.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.1 | 4.1 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
| 0.1 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.1 | 3.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.1 | 0.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.1 | 3.3 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
| 0.1 | 2.5 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
| 0.1 | 0.1 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
| 0.1 | 1.6 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
| 0.1 | 4.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.1 | 1.4 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
| 0.1 | 1.0 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
| 0.1 | 1.0 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
| 0.1 | 1.7 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.1 | 1.3 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.1 | 0.5 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
| 0.0 | 0.9 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
| 0.0 | 2.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.0 | 0.4 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.0 | 6.5 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.0 | 1.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.0 | 0.2 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.0 | 0.3 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.0 | 0.9 | REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM | Genes involved in Cytokine Signaling in Immune system |
| 0.0 | 0.0 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
| 0.0 | 0.4 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
| 0.0 | 1.0 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.0 | 1.8 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
| 0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.0 | 0.1 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |